General Electric (GE) 10-Q23 Apr 242024 Q1 Quarterly reportFinancial data

Company Profile

COVER

COVER	3 Months Ended
COVER	Mar. 31, 2024 shares
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2024
Document Transition Report	false
Entity File Number	001-00035
Entity Registrant Name	GENERAL ELECTRIC COMPANY
Amendment Flag	false
Entity Central Index Key	0000040545
Current Fiscal Year End Date	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2024
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	14-0689340
Entity Address, Address Line One	1 Neumann Way
Entity Address, City or Town	Evendale
Entity Address, State or Province	OH
Entity Address, Postal Zip Code	45215
City Area Code	617
Local Phone Number	443-3000
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding	1,094,606,676
Common Stock
Entity Information [Line Items]
Title of 12(b) Security	Common stock, par value $0.01 per share
Trading Symbol	GE
Security Exchange Name	NYSE
0.875% Notes Due 2025
Entity Information [Line Items]
Title of 12(b) Security	0.875% Notes due 2025
Trading Symbol	GE 25
Security Exchange Name	NYSE
1.875% Notes Due 2027
Entity Information [Line Items]
Title of 12(b) Security	1.875% Notes due 2027
Trading Symbol	GE 27E
Security Exchange Name	NYSE
1.500% Notes Due 2029
Entity Information [Line Items]
Title of 12(b) Security	1.500% Notes due 2029
Trading Symbol	GE 29
Security Exchange Name	NYSE
7.5% Guaranteed Subordinated Notes Due 2035
Entity Information [Line Items]
Title of 12(b) Security	7 1/2% Guaranteed Subordinated Notes due 2035
Trading Symbol	GE /35
Security Exchange Name	NYSE
2.125% Notes Due 2037
Entity Information [Line Items]
Title of 12(b) Security	2.125% Notes due 2037
Trading Symbol	GE 37
Security Exchange Name	NYSE

STATEMENT OF EARNINGS (LOSS) (U

STATEMENT OF EARNINGS (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenues
Insurance revenues (Note 13)	$ 879	$ 791
Total revenues (Note 8)	16,053	14,486
Costs and expenses
Selling, general and administrative expenses	2,269	2,142
Separation costs (Note 20)	355	205
Research and development	507	431
Interest and other financial charges	278	269
Insurance losses, annuity benefits and other costs (Note 13)	627	684
Non-operating benefit cost (income)	(362)	(385)
Total costs and expenses	15,295	14,075
Other income (loss) (Note 19)	1,109	6,081
Earnings (loss) from continuing operations before income taxes	1,866	6,492
Benefit (provision) for income taxes (Note 16)	(318)	(271)
Earnings (loss) from continuing operations	1,549	6,221
Earnings (loss) from discontinued operations, net of taxes (Note 2)	14	1,257
Net earnings (loss)	1,563	7,478
Less net earnings (loss) attributable to noncontrolling interests	27	(27)
Net earnings (loss) attributable to the Company	1,537	7,506
Preferred stock dividends and other	0	(145)
Net earnings (loss) attributable to GE common shareholders	1,537	7,360
Amounts attributable to GE common shareholders
Earnings (loss) from continuing operations	1,549	6,221
Less net earnings (loss) attributable to noncontrolling interests, continuing operations	27	(27)
Earnings (loss) from continuing operations attributable to the Company	1,522	6,248
Preferred stock dividends and other	0	(145)
Earnings (loss) from continuing operations attributable to GE common shareholders	1,522	6,103
Earnings (loss) from discontinued operations attributable to GE common shareholders	14	1,257
Net earnings (loss) attributable to GE common shareholders	$ 1,537	$ 7,360
Earnings (loss) per share from continuing operations (Note 18)
Diluted earnings (loss) per share (in dollars per share)	$ 1.38	$ 5.56
Basic earnings (loss) per share (in dollars per share)	1.39	5.60
Net earnings (loss) per share (Note 18)
Diluted earnings (loss) per share (in dollars per share)	1.39	6.71
Basic earnings (loss) per share (in dollars per share)	$ 1.41	$ 6.76
Equipment
Revenues
Sales	$ 5,935	$ 5,287
Costs and expenses
Cost of sales	6,024	5,605
Services
Revenues
Sales	9,239	8,407
Costs and expenses
Cost of sales	$ 5,596	$ 5,124

STATEMENT OF FINANCIAL POSITION

STATEMENT OF FINANCIAL POSITION - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Cash, cash equivalents and restricted cash	$ 18,447	$ 16,967
Investment securities (Note 3)	3,737	5,706
Current receivables (Note 4)	15,100	15,466
Inventories, including deferred inventory costs (Note 5)	17,603	16,528
Current contract assets (Note 9)	1,547	1,500
All other current assets (Note 10)	1,650	1,647
Assets of businesses held for sale (Note 2)	1,507	1,985
Current assets	59,589	59,799
Investment securities (Note 3)	38,705	38,000
Property, plant and equipment – net (Note 6)	12,345	12,494
Goodwill (Note 7)	13,304	13,385
Other intangible assets – net (Note 7)	5,547	5,695
Contract and other deferred assets (Note 9)	5,431	5,406
All other assets (Note 10)	16,995	15,997
Deferred income taxes (Note 16)	10,316	10,575
Assets of discontinued operations (Note 2)	1,709	1,695
Total assets	163,942	163,045
Short-term borrowings (Note 11)	1,032	1,253
Accounts payable and equipment project payables (Note 12)	15,184	15,408
Progress collections and current deferred income (Note 9)	20,718	19,677
All other current liabilities (Note 15)	12,342	12,712
Liabilities of businesses held for sale (Note 2)	1,811	1,826
Current liabilities	51,087	50,876
Deferred income (Note 9)	1,297	1,339
Long-term borrowings (Note 11)	19,493	19,711
Insurance liabilities and annuity benefits (Note 13)	37,934	39,624
Non-current compensation and benefits	11,002	11,214
All other liabilities (Note 15)	10,855	10,508
Liabilities of discontinued operations (Note 2)	1,169	1,193
Total liabilities	132,838	134,466
Common stock (Note 17)	15	15
Accumulated other comprehensive income (loss) – net attributable to GE (Note 17)	(5,603)	(6,150)
Other capital	25,887	26,962
Retained earnings	88,065	86,527
Less common stock held in treasury	(78,508)	(79,976)
Total GE shareholders’ equity	29,855	27,378
Noncontrolling interests	1,248	1,202
Total equity	31,104	28,579
Total liabilities and equity	$ 163,942	$ 163,045

STATEMENT OF CASH FLOWS

STATEMENT OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
STATEMENT OF CASH FLOWS - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Cash flows – operating activities
Net earnings (loss)	$ 1,563	$ 7,478
(Earnings) loss from discontinued operations activities	(14)	(1,257)
Adjustments to reconcile net earnings (loss) to cash from (used for) operating activities:
Depreciation and amortization of property, plant and equipment	378	367
Amortization of intangible assets (Note 7)	145	140
(Gains) losses on purchases and sales of business interests	(9)	52
(Gains) losses on retained and sold ownership interests and other equity securities (Note 19)	(665)	(5,906)
Principal pension plans cost (Note 14)	(256)	(271)
Principal pension plans employer contributions	(53)	(52)
Other postretirement benefit plans (net)	(133)	(181)
Provision (benefit) for income taxes	318	271
Cash recovered (paid) during the year for income taxes	(105)	(172)
Changes in operating working capital:
Decrease (increase) in current receivables	235	536
Decrease (increase) in inventories, including deferred inventory costs	(1,216)	(1,275)
Decrease (increase) in current contract assets	(72)	294
Increase (decrease) in accounts payable and equipment project payables	111	(201)
Increase (decrease) in progress collections and current deferred income	1,095	205
All other operating activities	(297)	128
Cash from (used for) operating activities – continuing operations	1,024	155
Cash from (used for) operating activities – discontinued operations	(32)	(413)
Cash from (used for) operating activities	992	(259)
Cash flows – investing activities
Additions to property, plant and equipment and internal-use software	(421)	(298)
Dispositions of property, plant and equipment	41	7
Dispositions of retained ownership interests	2,610	2,025
Net (purchases) dispositions of insurance investment securities	(1,141)	(1,556)
All other investing activities	(320)	1,096
Cash from (used for) investing activities – continuing operations	769	1,273
Cash from (used for) investing activities – discontinued operations	38	(3,068)
Cash from (used for) investing activities	808	(1,796)
Cash flows – financing activities
Net increase (decrease) in borrowings (maturities of 90 days or less)	(37)	1
Newly issued debt (maturities longer than 90 days)	0	9
Repayments and other debt reductions (maturities longer than 90 days)	(298)	(1,815)
Dividends paid to shareholders	(86)	(203)
Redemption of GE preferred stock	0	(3,000)
Purchases of GE common stock for treasury	(322)	(309)
All other financing activities	540	87
Cash from (used for) financing activities – continuing operations	(204)	(5,230)
Cash from (used for) financing activities – discontinued operations	0	1,999
Cash from (used for) financing activities	(204)	(3,232)
Effect of currency exchange rate changes on cash, cash equivalents and restricted cash	(61)	65
Increase (decrease) in cash, cash equivalents and restricted cash	1,534	(5,220)
Cash, cash equivalents and restricted cash at beginning of year	19,755	19,092
Cash, cash equivalents and restricted cash at March 31	21,290	13,871
Less cash, cash equivalents and restricted cash of discontinued operations at March 31	1,391	1,180
Cash, cash equivalents and restricted cash of continuing operations at March 31	$ 19,899	$ 12,691

STATEMENT OF COMPREHENSIVE INCO

STATEMENT OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 1,563	$ 7,478
Less: net earnings (loss) attributable to noncontrolling interests	27	(27)
Net earnings (loss) attributable to the Company	1,537	7,506
Other comprehensive income (loss)
Currency translation adjustments	(35)	2,387
Benefit plans	(198)	(2,319)
Investment securities and cash flow hedges	(453)	706
Long-duration insurance contracts	1,236	(1,793)
Less: other comprehensive income (loss) attributable to noncontrolling interests	2	(3)
Other comprehensive income (loss) attributable to the Company	547	(1,017)
Comprehensive income (loss)	2,112	6,458
Less: comprehensive income (loss) attributable to noncontrolling interests	28	(30)
Comprehensive income (loss) attributable to the Company	$ 2,084	$ 6,489

STATEMENT OF CHANGES IN SHAREHO

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Millions		Total	GE shareholders' equity balance	Accumulated other comprehensive income (loss)	Currency translation adjustments	Benefit plans	Investment securities and cash flow hedges	Long-duration insurance contracts	Other capital	Retained earnings	Common stock held in treasury	Noncontrolling interests balance
Beginning balance at Dec. 31, 2022				$ (2,272)			$ (1,927)	$ (983)	$ 34,173	$ 82,983	$ (81,209)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					$ 2,388	$ (2,317)	706	(1,793)
Purchases											(311)
Dispositions									(619)		759
Stock-based compensation									73
Other changes	[1]								(2,898)
Net earnings (loss) attributable to the Company		$ 7,506								7,506
Dividends and other transactions with shareholders	[2]									(5,534)
Ending balance at Mar. 31, 2023		32,823	$ 31,652	(3,289)	(3,505)	4,214	(1,222)	(2,776)	30,729	84,955	(80,762)	$ 1,171
Preferred stock issued		3
Common stock issued		15
Common stock issued		15
Beginning balance at Dec. 31, 2023		28,579		(6,150)			(959)	(3,354)	26,962	86,527	(79,976)
Increase (decrease) in shareholders' equity
Other comprehensive income (loss)					(35)	(200)	(453)	1,236
Purchases											(317)
Dispositions									(1,191)		1,785
Stock-based compensation									114
Other changes	[1]								2
Net earnings (loss) attributable to the Company		1,537								1,537
Dividends and other transactions with shareholders	[2]									1
Ending balance at Mar. 31, 2024		31,104	$ 29,855	$ (5,603)	$ (3,658)	$ 1,586	$ (1,412)	$ (2,119)	$ 25,887	$ 88,065	$ (78,508)	$ 1,248
Preferred stock issued		0
Common stock issued		$ 15

[1]Included $3,000 million decrease substantially all in Other capital related to our redemption of GE Series D preferred stock in the first quarter of 2023.[2]Included a $5,300 million decrease in Retained earnings reflecting a pro-rata distribution of approximately 80.1% of the shares of GE HealthCare on January 3, 2023.

STATEMENT OF CHANGES IN SHARE_2

STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical) $ in Millions	Jan. 03, 2023 USD ($)
Spinoff \| GE HealthCare
Ownership interest disposed of	80.10%
Retained earnings
Spinoff transaction adjustment	$ 5,300

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1. BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications. We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off. See Note 2 for further information. On April 2, 2024, GE completed the separation of its GE Vernova business into a separate, independent publicly traded company, GE Vernova Inc. (GE Vernova). See Note 24 for further information.

BUSINESSES HELD FOR SALE AND DI

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	3 Months Ended
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS	NOTE 2. BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS. In the fourth quarter of 2022, we signed a binding agreement to sell a portion of our Steam business within our Power segment to Électricité de France S.A. (EDF). We are working with EDF to complete the sale as soon as possible, subject to regulatory approvals and other closing conditions. Closing the transaction is expected to result in a significant gain. In the fourth quarter of 2022, we classified our captive industrial insurance subsidiary, Electric Insurance Company, domiciled in Massachusetts, with assets of $514 million and liabilities of $339 million as of March 31, 2024, into held for sale. In the third quarter of 2023, we signed a binding agreement to sell this business and expect to complete the sale, subject to regulatory approvals and other customary closing conditions, in the second quarter of 2024. In connection with the expected sale, to date we have recorded a cumulative loss of $126 million in Other income (loss) in our Statement of Earnings (Loss). ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE March 31, 2024 December 31, 2023 Cash and cash equivalents $ 88 $ 609 Current receivables, inventories and contract assets 633 551 Non-current captive insurance investment securities 548 570 Property, plant and equipment and intangible assets - net 253 254 Valuation allowance on disposal group classified as held for sale (124) (124) All other assets 108 125 Assets of businesses held for sale $ 1,507 $ 1,985 Progress collections and deferred income $ 964 $ 1,001 Insurance liabilities and annuity benefits 344 376 Accounts payable, equipment project payables and other current liabilities 463 392 All other liabilities 40 57 Liabilities of businesses held for sale $ 1,811 $ 1,826 DISCONTINUED OPERATIONS primarily comprise our former GE HealthCare business, our mortgage portfolio in Poland (Bank BPH), and other trailing assets and liabilities associated with prior dispositions. Results of operations, financial position and cash flows for these businesses are reported as discontinued operations for all periods presented and the notes to the financial statements have been adjusted on a retrospective basis. GE HealthCare. On January 3, 2023, we completed the previously announced separation of our HealthCare business (the Separation), into a separate, independent, publicly traded company, GE HealthCare Technologies Inc. (GE HealthCare). The Separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of approximately 80.1% of the outstanding shares of GE HealthCare to holders of GE common stock. In connection with the Separation, the historical results of GE HealthCare and certain assets and liabilities included in the Separation are reported in GE's consolidated financial statements as discontinued operations. We have continuing involvement with GE HealthCare primarily through a transition services agreement, through which GE and GE HealthCare continue to provide certain services to each other for a period of time following the Separation, and a trademark licensing agreement. For the three months ended March 31, 2024, we collected net cash of $115 million related to these activities. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded a charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,517 million and $2,669 million as of March 31, 2024 and December 31, 2023, respectively. In order to maintain appropriate regulatory capital levels, during the year ended December 31, 2023, we made the previously reported non-cash capital contributions in the form of intercompany loan forgiveness of $1,797 million; no incremental contributions from GE were required during the three months ended March 31, 2024. For further information about the recent actions and other factors that are relevant to the estimate of total losses for borrower litigation at Bank BPH, see Note 23. Future changes or adverse developments could increase our estimate of total losses and potentially require future cash contributions to Bank BPH. The Bank BPH financing receivable portfolio is recorded at the lower of cost or fair value, less cost to sell, which reflects market yields and estimates with respect to ongoing borrower litigation. Earnings (loss) from discontinued operations included zero and $175 million in pre-tax charges for the three months ended March 31, 2024 and 2023, respectively, primarily related to the ongoing borrower litigation. At March 31, 2024, the total portfolio had a carrying value of zero, net of a valuation allowance. 2024 2023 RESULTS OF DISCONTINUED OPERATIONS Three months ended March 31 GE HealthCare Bank BPH & Other Total GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ — $ — $ — Cost of equipment and services sold — — — — — — Other income, costs and expenses — 6 6 (20) (201) (221) Earnings (loss) of discontinued operations before income taxes — 6 6 (20) (201) (221) Benefit (provision) for income taxes — 6 6 1,479 (1) 1,478 Earnings (loss) of discontinued operations, net of taxes — 12 12 1,459 (202) 1,257 Gain (loss) on disposal before income taxes — 2 2 — — — Benefit (provision) for income taxes — — — — — — Gain (loss) on disposal, net of taxes — 2 2 — — — Earnings (loss) from discontinued operations, net of taxes $ — $ 14 $ 14 $ 1,459 $ (202) $ 1,257 The tax benefit for the three months ended March 31, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS March 31, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 1,391 $ 1,396 Current receivables 13 14 Property, plant and equipment - net 52 58 All other assets 224 200 Deferred income taxes 29 27 Assets of discontinued operations(a) $ 1,709 $ 1,695 Accounts payable and equipment project payables $ 34 $ 36 Non-current compensation and benefits 35 31 All other liabilities(a) 1,101 1,125 Liabilities of discontinued operations $ 1,169 $ 1,193 (a) Included $1,792 million and $1,963 million of valuation allowances against financing receivables held for sale, of which $1,553 million and $1,712 million related to estimated borrower litigation losses, and $964 million and $957 million in All other liabilities, related to estimated borrower litigation losses for Bank BPH’s foreign currency-denominated mortgage portfolio, as of March 31, 2024 and December 31, 2023, respectively. Accordingly, total estimated losses related to borrower litigation were $2,517 million and $2,669 million as of March 31, 2024 and December 31, 2023, respectively. As a result of the settlement program, the valuation allowance completely offsets the financing receivables balance as of March 31, 2024.

INVESTMENT SECURITIES

INVESTMENT SECURITIES	3 Months Ended
INVESTMENT SECURITIES	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
INVESTMENT SECURITIES	NOTE 3. INVESTMENT SECURITIES. The majority of our investment securities are held within our run-off insurance operations and are classified as non-current as they support the long-duration insurance liabilities and include debt securities all classified as available-for-sale, substantially all of which are investment-grade. Our remaining equity shares in GE HealthCare, comprising 30.5 million shares (approximately 6.7% ownership interest) at March 31, 2024, are subject to a contractual lock-up restriction through May 15, 2024. Our senior note from AerCap, for which we have adopted the fair value option and matures in the fourth quarter of 2025, is still outstanding as of March 31, 2024. March 31, 2024 December 31, 2023 Amortized Gross Gross Estimated Amortized Gross Gross Estimated GE HealthCare equity $ — $ — $ — $ 2,776 $ — $ — $ — $ 4,761 AerCap note — — — 961 — — — 944 Current investment securities $ — $ — $ — $ 3,737 $ — $ — $ — $ 5,706 Debt U.S. corporate $ 27,477 $ 757 $ (1,870) $ 26,365 $ 27,495 $ 1,034 $ (1,606) $ 26,923 Non-U.S. corporate 2,509 26 (236) 2,299 2,529 34 (209) 2,353 State and municipal 2,803 54 (204) 2,654 2,828 79 (185) 2,723 Mortgage and asset-backed 4,878 36 (226) 4,688 4,827 34 (291) 4,571 Government and agencies 2,478 1 (125) 2,355 1,213 3 (116) 1,100 Other equity 344 — — 344 331 — — 331 Non-current investment securities $ 40,491 $ 875 $ (2,661) $ 38,705 $ 39,222 $ 1,183 $ (2,406) $ 38,000 The amortized cost of debt securities excludes accrued interest of $496 million and $466 million at March 31, 2024 and December 31, 2023, respectively , which is reported in All other current assets. The estimated fair value of investment securities at March 31, 2024 decreased since December 31, 2023, primarily due to share sales of our GE HealthCare equity interest and higher market yields partially offset by new investments at Insurance and the mark-to-market effect on our equity interest in GE HealthCare. Total estimated fair value of debt securities in an unrealized loss position were $20,413 million and $18,730 million, of which $16,711 million and $17,146 million had gross unrealized losses of $(2,584) million and $(2,370) million and had been in a loss position for 12 months or more at March 31, 2024 and December 31, 2023, respectively. At March 31, 2024, the majority of our U.S. and Non-U.S. corporate securities' gross unrealized losses were in the consumer, electric, technology and insurance industries. In addition, gross unrealized losses on our Mortgage and asset-backed securities included $(149) million related to commercial mortgage-backed securities (CMBS) collateralized by pools of commercial mortgage loans on real estate, and $(68) million related to asset-backed securities. The majority of our CMBS and asset-backed securities in an unrealized loss position have received investment-grade credit ratings from the major rating agencies. For our securities in an unrealized loss position, the losses are not indicative of credit losses, we currently do not intend to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis. Three months ended March 31 2024 2023 Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) $ 441 $ 6,040 Proceeds from debt/equity securities sales and early redemptions 3,196 3,008 Gross realized gains on debt securities 8 11 Gross realized losses and impairments on debt securities (11) (21) Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at March 31, 2024 are as follows: Amortized cost Estimated fair value Within one year $ 1,756 $ 1,751 After one year through five years 5,149 5,170 After five years through ten years 5,132 5,178 After ten years 23,231 21,574 We expect actual maturities to differ from contractual maturities because borrowers have the right to call or prepay certain obligations. The majority of our equity securities are classified within Level 1 and the majority of our debt securities are classified within Level 2, as their valuation is determined based on significant observable inputs. Investments with a fair value of $6,991 million and $6,841 million are classified within Level 3, as significant inputs to their valuation models are unobservable at March 31, 2024 and December 31, 2023, respectively. During the three months ended March 31, 2024 and 2023, there were no significant transfers into or out of Level 3. In addition to the equity securities described above, we held $1,092 million and $1,012 million of equity securities without RDFV, including $1,019 million and $939 million at Insurance, as of March 31, 2024 and December 31, 2023, respectively, that are classified within non-current All other assets in our Statement of Financial Position. Fair value adjustments, including impairments, recorded in earnings were $23 million and $9 million for the three months ended March 31, 2024 and 2023, respectively. These are primarily limited partnership investments in private equity, infrastructure and real estate funds that are measured at net asset value per share (or equivalent) as a practical expedient to estimated fair value and are excluded from the fair value hierarchy.

CURRENT AND LONG-TERM RECEIVABL

CURRENT AND LONG-TERM RECEIVABLES	3 Months Ended
CURRENT AND LONG-TERM RECEIVABLES	Mar. 31, 2024
Receivables [Abstract]
CURRENT AND LONG-TERM RECEIVABLES	NOTE 4. CURRENT AND LONG-TERM RECEIVABLES CURRENT RECEIVABLES March 31, 2024 December 31, 2023 Customer receivables $ 11,952 $ 12,349 Revenue sharing program receivables(a) 1,134 1,252 Non-income based tax receivables 1,225 1,140 Supplier advances 924 891 Receivables from disposed businesses 61 121 Other sundry receivables 450 360 Allowance for credit losses (646) (647) Total current receivables $ 15,100 $ 15,466 (a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. ALLOWANCE FOR CREDIT LOSSES March 31, 2024 March 31, 2023 Balances as of January 1 $ 647 $ 768 New provisions, net of (releases) — 20 Write-offs, net — (4) Foreign exchange and other — 4 Ending balance $ 646 $ 787 March 31, 2024 December 31, 2023 Aerospace $ 7,848 $ 8,010 Renewable Energy 3,097 2,907 Power 4,332 4,232 Corporate(a) (177) 318 Total current receivables $ 15,100 $ 15,466 (a) Corporate balances include intercompany eliminations related to the sales of equipment and services. Sales of customer receivables. From time to time, the Company sells current or long-term receivables to third parties in response to customer-sponsored requests or programs, to facilitate sales, or for risk mitigation purposes. The Company sold current customer receivables to third parties and subsequently collected $306 million and $464 million in the three months ended March 31, 2024 and 2023, respectively, related primarily to our participation in customer-sponsored supply chain finance programs. Within these programs, primarily in Renewable Energy and Aerospace, the Company has no continuing involvement; fees associated with the transferred receivables are covered by the customer and cash is received at the original invoice due date. Included in the sales of customer receivables in the first quarter of 2023 , was $77 million in our Gas Power business, primarily for risk mitigation purposes. LONG-TERM RECEIVABLES March 31, 2024 December 31, 2023 Long-term customer receivables $ 459 $ 479 Supplier advances 271 274 Non-income based tax receivables 146 174 Sundry receivables 343 373 Allowance for credit losses (167) (171) Total long-term receivables $ 1,052 $ 1,129

INVENTORIES, INCLUDING DEFERRED

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	3 Months Ended
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	Mar. 31, 2024
Inventory Disclosure [Abstract]
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS	NOTE 5. INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS March 31, 2024 December 31, 2023 Raw materials and work in process $ 11,665 $ 11,209 Finished goods 3,952 3,720 Deferred inventory costs(a) 1,986 1,599 Inventories, including deferred inventory costs $ 17,603 $ 16,528

PROPERTY, PLANT AND EQUIPMENT A

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	3 Months Ended
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES	NOTE 6. PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES March 31, 2024 December 31, 2023 Original cost $ 27,498 $ 27,332 Less: accumulated depreciation and amortization (16,935) (16,678) Right-of-use operating lease assets 1,782 1,840 Property, plant and equipment – net $ 12,345 $ 12,494 Operating Lease Liabilities. Our consolidated operating lease liabilities, included in All other liabilities

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	3 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 7. GOODWILL AND OTHER INTANGIBLE ASSETS GOODWILL January 1, 2024 Acquisitions Currency exchange Balance at March 31, 2024 Aerospace $ 8,948 $ — $ (46) $ 8,902 Renewable Energy 3,287 — (34) 3,253 Power 307 4 (1) 311 Corporate(a) 842 — (4) 838 Total $ 13,385 $ 4 $ (84) $ 13,304 (a) Corporate balance comprises our Digital business. We assess the possibility that a reporting unit’s fair value has been reduced below its carrying amount due to the occurrence of events or circumstances between annual impairment testing dates. In the first quarter of 2024, we did not identify any reporting units that required an interim impairment test. However, we continue to monitor the operating results and cash flow forecasts of our Additive reporting unit in our Aerospace segment as the fair value of this reporting unit was not significantly in excess of its carrying value based on the results of our most recent annual impairment test, performed in the fourth quarter of 2023. At March 31, 2024, our Additive reporting unit had goodwill of $244 million. Intangible assets decreased $148 million during the three months ended March 31, 2024, primarily as a result of amortization. Consolidated amortization expense was $145 million and $140 million in the three months ended March 31, 2024 and 2023, respectively.

REVENUES

REVENUES	3 Months Ended
REVENUES	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
REVENUES	NOTE 8. REVENUES EQUIPMENT & SERVICES REVENUES Three months ended March 31 2024 2023 Equipment Services Total Equipment Services Total Aerospace $ 2,421 $ 5,643 $ 8,064 $ 1,974 $ 5,007 $ 6,981 Renewable Energy 2,458 547 3,005 2,311 527 2,837 Power 1,185 2,949 4,134 1,102 2,718 3,820 Total segment revenues $ 6,064 $ 9,139 $ 15,203 $ 5,387 $ 8,252 $ 13,638 REVENUES Three months ended March 31 2024 2023 Commercial Engines and Services $ 6,064 $ 5,194 Defense and Propulsion Technologies 2,301 1,961 Eliminations & Other (301) (173) Aerospace(a) $ 8,064 $ 6,981 Onshore Wind $ 1,198 $ 1,502 Grid Solutions equipment and services 1,085 824 Hydro, Offshore Wind and Hybrid Solutions 722 511 Renewable Energy $ 3,005 $ 2,837 Gas Power $ 3,068 $ 2,867 Steam Power 584 541 Power Conversion, Nuclear and other 483 412 Power $ 4,134 $ 3,820 Total segment revenues $ 15,203 $ 13,638 GE Digital revenues $ 209 $ 237 Insurance revenues 879 791 Eliminations and other (237) (181) Corporate $ 850 $ 848 Total revenues $ 16,053 $ 14,486 (a) Does not give effect to post-GE Vernova separation eliminations and Corporate adjustments. REMAINING PERFORMANCE OBLIGATION.

CONTRACT AND OTHER DEFERRED ASS

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME	3 Months Ended
	Mar. 31, 2024
Contractors [Abstract]
CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME	NOTE 9. CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME Contract and other deferred assets increased $72 million in the three months ended March 31, 2024, primarily due to the timing of revenue recognition ahead of billing milestones on long-term equipment contracts and short-term and other services agreements, partially offset by a decrease in long-term service agreements. Our long-term service agreements decreased primarily due to billings of $3,155 million and net unfavorable changes in estimated profitability of $162 million at Aerospace and $29 million at Power, partially offset by revenues recognized of $3,029 million. March 31, 2024 Aerospace Renewable Energy Power Corporate Total Revenues in excess of billings $ 2,112 $ — $ 5,176 $ — $ 7,288 Billings in excess of revenues (7,965) — (1,794) — (9,759) Long-term service agreements $ (5,853) $ — $ 3,382 $ — $ (2,471) Equipment and other service agreements 603 1,628 1,506 281 4,018 Current contract assets $ (5,250) $ 1,628 $ 4,888 $ 281 $ 1,547 Nonrecurring engineering costs(a) 2,444 23 1 — 2,469 Customer advances and other(b) 2,353 — 609 — 2,963 Non-current contract and other deferred assets $ 4,798 $ 23 $ 611 $ — $ 5,431 Total contract and other deferred assets $ (452) $ 1,651 $ 5,499 $ 281 $ 6,978 December 31, 2023 Revenues in excess of billings $ 2,377 $ — $ 5,205 $ — $ 7,582 Billings in excess of revenues (7,902) — (1,810) — (9,712) Long-term service agreements $ (5,525) $ — $ 3,395 $ — $ (2,130) Equipment and other service agreements 494 1,374 1,499 263 3,630 Current contract assets $ (5,030) $ 1,374 $ 4,894 $ 263 $ 1,500 Nonrecurring engineering costs(a) 2,444 18 1 — 2,463 Customer advances and other(b) 2,342 — 601 — 2,943 Non-current contract and other deferred assets $ 4,785 $ 18 $ 603 $ — $ 5,406 Total contract and other deferred assets $ (245) $ 1,392 $ 5,497 $ 263 $ 6,907 (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced. (b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements. Progress collections and deferred income increased $999 million primarily due to collections received in excess of revenue recognition at Renewable Energy, Power and Aerospace. Revenues recognized for contracts included in a liability position at the beginning of the year were $4,628 million and $4,468 million for the three months ended March 31, 2024 and 2023, respectively. March 31, 2024 Aerospace Renewable Energy Power Corporate Total Progress collections $ 6,401 $ 7,554 $ 6,091 $ 134 $ 20,180 Current deferred income 179 221 11 127 539 Progress collections and current deferred income $ 6,580 $ 7,775 $ 6,103 $ 261 $ 20,718 Non-current deferred income 1,084 149 46 19 1,297 Total Progress collections and deferred income $ 7,664 $ 7,924 $ 6,148 $ 279 $ 22,016 December 31, 2023 Progress collections $ 6,198 $ 6,886 $ 5,898 $ 124 $ 19,106 Current deferred income 201 239 20 112 571 Progress collections and current deferred income $ 6,399 $ 7,125 $ 5,918 $ 236 $ 19,677 Non-current deferred income 1,150 122 48 20 1,339 Total Progress collections and deferred income $ 7,549 $ 7,247 $ 5,965 $ 256 $ 21,017

ALL OTHER ASSETS

ALL OTHER ASSETS	3 Months Ended
ALL OTHER ASSETS	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
ALL OTHER ASSETS	NOTE 10. ALL OTHER ASSETS. All other current assets and All other assets primarily include equity method investments, Insurance cash and cash equivalents, receivables and other investments in our run-off insurance operations, long-term customer and sundry receivables (see Note 4), pension surplus and prepaid taxes and other deferred charges. All other non-current assets increased $999 million in the three months ended March 31, 2024, primarily due to an increase in Insurance cash and cash equivalents of $581 million, an increase in equity method investments of $229 million and an increase in prepaid taxes and deferred charges of $179 million. Insurance cash and cash equivalents was $1,364 million and $784 million at March 31, 2024 and December 31, 2023, respectively.

BORROWINGS

BORROWINGS	3 Months Ended
BORROWINGS	Mar. 31, 2024
Debt Disclosure [Abstract]
BORROWINGS	NOTE 11. BORROWINGS March 31, 2024 December 31, 2023 Current portion of long-term borrowings Senior notes $ 879 $ 1,044 Subordinated notes and other 81 107 Other short term borrowings 72 103 Total short-term borrowings $ 1,032 $ 1,253 Senior notes 17,351 $ 17,509 Subordinated notes 1,370 1,383 Other 772 819 Total long-term borrowings $ 19,493 $ 19,711 Total borrowings $ 20,525 $ 20,965

ACCOUNTS PAYABLE AND EQUIPMENT

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	3 Months Ended
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	Mar. 31, 2024
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES	NOTE 12. ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES March 31, 2024 December 31, 2023 Trade payables $ 10,486 $ 10,678 Supply chain finance programs 3,124 3,133 Equipment project payables(a) 1,117 1,193 Non-income based tax payables 456 403 Accounts payable and equipment project payables $ 15,184 $ 15,408 (a) Primarily related to projects at Power and Renewable Energy. We facilitate voluntary supply chain finance programs with third parties, which provide participating suppliers the opportunity to sell their GE receivables to third parties at the sole discretion of both the suppliers and the third parties. Total supplier invoices paid through these third-party programs were $1,705 million and $2,079 million for the three months ended March 31, 2024 and 2023, respectively.

INSURANCE LIABILITIES AND ANNUI

INSURANCE LIABILITIES AND ANNUITY BENEFITS	3 Months Ended
INSURANCE LIABILITIES AND ANNUITY BENEFITS	Mar. 31, 2024
Insurance [Abstract]
INSURANCE LIABILITIES AND ANNUITY BENEFITS	NOTE 13. INSURANCE LIABILITIES AND ANNUITY BENEFITS. Insurance liabilities and annuity benefits comprise substantially all obligations to annuitants and insureds in our run-off insurance operations. Our insurance operations (net of eliminations) generated revenues of $879 million and $791 million, profit was $200 million and $70 million and net earnings was $158 million and $54 million for the three months ended March 31, 2024 and 2023, respectively. These operations were primarily supported by investment securities of $38,304 million and $37,592 million, limited partnerships of $3,498 million and $3,300 million, and a diversified commercial mortgage loan portfolio substantially all collateralized by first liens on U.S. commercial real estate properties of $1,924 million and $1,947 million (net of allowance for credit losses of $61 million and $48 million), as of March 31, 2024 and December 31, 2023, respectively. As of March 31, 2024, the commercial mortgage loan portfolio had 4 delinquent loans, 1 non-accrual loan and about one-third of the portfolio was held in the office sector, which had a weighted average loan-to-value ratio of 70%, debt service coverage of 1.6, and no scheduled maturities through 2025. A summary of our insurance liabilities and annuity benefits is presented below: March 31, 2024 Long-term care Structured settlement annuities Life Other contracts Total Future policy benefit reserves $ 25,722 $ 8,909 $ 1,054 $ 375 $ 36,059 Investment contracts — 776 — 710 1,486 Other — — 112 277 389 Total $ 25,722 $ 9,685 $ 1,166 $ 1,361 $ 37,934 December 31, 2023 Future policy benefit reserves $ 26,832 $ 9,357 $ 1,117 $ 382 $ 37,689 Investment contracts — 793 — 742 1,535 Other — — 116 285 400 Total $ 26,832 $ 10,150 $ 1,233 $ 1,409 $ 39,624 The following tables summarize balances of and changes in future policy benefits reserves. March 31, 2024 March 31, 2023 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,063 $ — $ 4,803 $ 4,059 $ — $ 4,828 Beginning balance at locked-in discount rate 3,745 — 4,773 3,958 — 5,210 Effect of changes in cash flow assumptions 17 — — — — — Effect of actual variances from expected experience 6 — (2) 29 — (35) Adjusted beginning of year balance 3,769 — 4,771 3,987 — 5,175 Interest accrual 51 — 45 53 — 50 Net premiums collected (98) — (70) (103) — (73) Effect of foreign currency — — (69) — — (23) Ending balance at locked-in discount rate 3,721 — 4,678 3,936 — 5,129 Effect of changes in discount rate assumptions 211 — (151) 281 — (149) Balance, end of period $ 3,932 $ — $ 4,527 $ 4,217 $ — $ 4,979 Present value of expected future policy benefits Balance, beginning of year $ 30,895 $ 9,357 $ 5,921 $ 28,316 $ 8,860 $ 5,868 Beginning balance at locked-in discount rate 27,144 8,561 5,847 27,026 8,790 6,247 Effect of changes in cash flow assumptions (7) — — (11) — — Effect of actual variances from expected experience 43 (29) (13) 30 (1) 2 Adjusted beginning of year balance 27,180 8,532 5,833 27,046 8,789 6,250 Interest accrual 368 111 55 363 115 60 Benefit payments (359) (159) (109) (309) (174) (138) Effect of foreign currency — — (73) — — (24) Ending balance at locked-in discount rate 27,190 8,484 5,707 27,100 8,730 6,148 Effect of changes in discount rate assumptions 2,465 425 (126) 3,171 619 (123) Balance, end of period $ 29,654 $ 8,909 $ 5,581 $ 30,271 $ 9,349 $ 6,025 Net future policy benefit reserves $ 25,722 $ 8,909 $ 1,054 $ 26,054 $ 9,349 $ 1,045 Less: Reinsurance recoverables, net of allowance for credit losses (165) — (29) (204) — (57) Net future policy benefit reserves, after reinsurance recoverables $ 25,557 $ 8,909 $ 1,025 $ 25,850 $ 9,349 $ 988 The Statement of Earnings (Loss) for the three months ended March 31, 2024 and 2023 included gross premiums or assessments of $207 million and $214 million and interest accretion of $439 million and $435 million, respectively. For the three months ended March 31, 2024 and 2023, gross premiums or assessments were substantially all related to long-term care of $123 million and $124 million and life of $79 million and $84 million, while interest accretion was substantially all related to long-term care of $318 million and $310 million and structured settlement annuities of $111 million and $115 million, respectively. The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses for nonparticipating traditional contracts. March 31, 2024 March 31, 2023 Undiscounted Discounted(a) Undiscounted Discounted(a) Long-term care: Gross premiums $ 7,376 $ 4,794 $ 7,924 $ 5,105 Benefit payments 62,774 29,654 64,944 30,271 Structured settlement annuities: Benefit payments 19,092 8,909 19,745 9,349 Life: Gross premiums 12,082 5,446 13,537 6,104 Benefit payments 10,935 5,581 11,800 6,025 (a) Determined using the current discount rate as of March 31, 2024 and 2023, respectively. The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits. March 31, 2024 March 31, 2023 Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Duration (years)(a) 12.4 10.8 5.3 13.2 11.2 5.3 Interest accretion rate 5.6% 5.4% 5.2% 5.5% 5.4% 5.1% Current discount rate 5.2% 5.2% 5.0% 5.0% 5.0% 4.8% (a) Determined using the current discount rate as of March 31, 2024 and 2023. As of March 31, 2024 and 2023, policyholders account balances totaled $1,686 million and $1,921 million, respectively. As our insurance operations are in run-off, changes in policyholder account balances for the three months ended March 31, 2024 and 2023 are primarily attributed to surrenders, withdrawals, and benefit payments of $106 million and $120 million, partially offset by net additions from separate accounts and interest credited of $66 million and $75 million, respectively. Interest on policyholder account balances is generally credited at minimum guaranteed rates, primarily between 3.0% and 6.0% at both March 31, 2024 and 2023. Following approval of a statutory permitted accounting practice in 2018 by our primary regulator, the Kansas Insurance Department, we have since provided a total of $15,035 million of capital contributions to our run-off insurance subsidiaries, including the final contribution of $1,820 million in the first quarter of 2024. See Notes 3 and 10 for further information related to our run-off insurance operations.

POSTRETIREMENT BENEFIT PLANS

POSTRETIREMENT BENEFIT PLANS	3 Months Ended
POSTRETIREMENT BENEFIT PLANS	Mar. 31, 2024
Retirement Benefits [Abstract]
POSTRETIREMENT BENEFIT PLANS	NOTE 14. POSTRETIREMENT BENEFIT PLANS. We sponsor a number of pension and retiree health and life insurance benefit plans that we present in three categories, principal pension plans, other pension plans and principal retiree benefit plans. Please refer to Note 13 to the consolidated financial statements of our Annual Report on Form 10-K for the year ended December 31, 2023 and Note 24 for further information. The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended March 31 2024 2023 Service cost for benefits earned $ 21 $ 21 Expected return on plan assets (578) (594) Interest cost on benefit obligations 453 474 Net actuarial loss amortization and other (152) (172) Net periodic expense (income) $ (256) $ (271) Principal retiree benefit plans income was $36 million and $36 million for the three months ended March 31, 2024 and 2023, respectively. Other pension plans income was $13 million and $29 million for the three months ended March 31, 2024 and 2023, respectively. We have a defined contribution plan for eligible U.S. employees that provides employer contributions, which were $89 million and $77 million for the three months ended March 31, 2024 and 2023, respectively. We also have deferred incentive compensation plans and deferred salary plans for eligible employees with expenses of $9 million and $20 million for the three months ended March 31, 2024 and 2023.

CURRENT AND ALL OTHER LIABILITI

CURRENT AND ALL OTHER LIABILITIES	3 Months Ended
CURRENT AND ALL OTHER LIABILITIES	Mar. 31, 2024
Other Liabilities Disclosure [Abstract]
CURRENT AND ALL OTHER LIABILITIES	NOTE 15. CURRENT AND ALL OTHER LIABILITIES.

INCOME TAXES

INCOME TAXES	3 Months Ended
INCOME TAXES	Mar. 31, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 16. INCOME TAXES. Our effective income tax rate was 17.0% and 4.2% for the three months ended March 31, 2024 and 2023, respectively. The tax rate for 2024 was reduced compared to the U.S. statutory rate of 21% primarily due to gains associated with our retained and sold ownership interests, which we expect to recover without tax and U.S. business credits. This was partially offset by losses in foreign jurisdictions that are not likely to be utilized. The low tax rate for 2023 was reduced compared to the U.S. statutory rate of 21% primarily due to gains associated with our retained and sold ownership interests, which we expect to recover without tax. This was partially offset by separation income tax costs including disallowed expenses and valuation allowances related to the spin of GE HealthCare and by losses in foreign jurisdictions that are not likely to be utilized. The OECD (Organisation for Economic Co-operation and Development) has proposed a global minimum tax of 15% of reported profits (Pillar 2) that has been agreed upon in principle by over 140 countries. During 2023, many countries took steps to incorporate Pillar 2 model rule concepts into their domestic laws. Although the model rules provide a framework for applying the minimum tax, countries may enact Pillar 2 slightly differently than the model rules and on different timelines and may adjust domestic tax incentives in response to Pillar 2. Accordingly, we still are evaluating the potential consequences of Pillar 2 on our longer-term financial position. In 2024, we expect to incur insignificant tax expenses in connection with Pillar 2.

SHAREHOLDERS' EQUITY

SHAREHOLDERS' EQUITY	3 Months Ended
SHAREHOLDERS' EQUITY	Mar. 31, 2024
Equity [Abstract]
SHAREHOLDERS' EQUITY	NOTE 17. SHAREHOLDERS’ EQUITY ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Three months ended March 31 (Dividends per share in dollars) 2024 2023 Beginning balance $ (3,623) $ (5,893) AOCI before reclasses – net of taxes of $26 and $(5) (35) 152 Reclasses from AOCI – net of taxes of $— and $(626)(a) — 2,234 AOCI (35) 2,387 Less AOCI attributable to noncontrolling interests — (1) Currency translation adjustments AOCI $ (3,658) $ (3,505) Beginning balance $ 1,786 $ 6,531 AOCI before reclasses – net of taxes of $8 and $(13) (29) (84) Reclasses from AOCI – net of taxes of $(52) and $(594)(a) (168) (2,235) AOCI (197) (2,319) Less AOCI attributable to noncontrolling interests 2 (2) Benefit plans AOCI $ 1,586 $ 4,214 Beginning balance $ (959) $ (1,927) AOCI before reclasses – net of taxes of $(116) and $188 (465) 718 Reclasses from AOCI – net of taxes of $0 and $0(a) 11 (12) AOCI (453) 706 Investment securities and cash flow hedges AOCI $ (1,412) $ (1,222) Beginning balance $ (3,354) $ (983) AOCI before reclasses – net of taxes of $328 and $(477) 1,236 (1,793) AOCI 1,236 (1,793) Long-duration insurance contracts AOCI $ (2,119) $ (2,776) AOCI at March 31 $ (5,603) $ (3,289) Dividends declared per common share $ — $ 0.08 (a) The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in first quarter of 2023 related to the spin-off of GE HealthCare. Preferred stock. On September 15, 2023 we redeemed the remaining outstanding shares of GE preferred stock. GE preferred stock shares outstanding was 2,795,444 at March 31, 2023. We redeemed $3,000 million of GE Series D preferred stock in the first quarter of 2023. Common stock. GE common stock shares outstanding were 1,094,606,676 and 1,088,415,995 at March 31, 2024 and December 31, 2023, respectively. For further information on our common and preferred stock issuances, please refer to our Annual Report on Form 10-K for the year ended December 31, 2023.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION	3 Months Ended
EARNINGS PER SHARE INFORMATION	Mar. 31, 2024
Earnings Per Share [Abstract]
EARNINGS PER SHARE INFORMATION	NOTE 18. EARNINGS PER SHARE INFORMATION Three months ended March 31 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 1,522 $ 1,522 $ 6,242 $ 6,248 Preferred stock dividends and other and accretion of preferred share repurchase(a) — — (145) (145) Earnings (loss) from continuing operations attributable to common shareholders 1,522 1,522 6,097 6,103 Earnings (loss) from discontinued operations 14 14 1,257 1,257 Net earnings (loss) attributable to GE common shareholders 1,537 1,537 7,354 7,360 Shares of GE common stock outstanding 1,091 1,091 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 8 — Total average equivalent shares 1,103 1,091 1,097 1,089 Earnings (loss) per share from continuing operations $ 1.38 $ 1.39 $ 5.56 $ 5.60 Earnings (loss) per share from discontinued operations 0.01 0.01 1.15 1.15 Net earnings (loss) per share 1.39 1.41 6.71 6.76 Potentially dilutive securities(b) 12 38 (a) For the three months ended March 31, 2023, included $(30) million related to excise tax on preferred share redemptions. (b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive. Our unvested restricted stock unit awards that contain non-forfeitable rights to dividends or dividend equivalents are considered participating securities and, therefore, are included in the computation of earnings per share pursuant to the two-class method. For the three months ended March 31, 2024 and 2023, application of this treatment had an insignificant effect.

OTHER INCOME (LOSS)

OTHER INCOME (LOSS)	3 Months Ended
OTHER INCOME (LOSS)	Mar. 31, 2024
Other Income and Expenses [Abstract]
OTHER INCOME (LOSS)	NOTE 19. OTHER INCOME (LOSS) Three months ended March 31 2024 2023 Investment in GE HealthCare realized and unrealized gain (loss) $ 616 $ 6,093 Investment in and note with AerCap realized and unrealized gain (loss) 12 (195) Investment in Baker Hughes realized and unrealized gain (loss) — 10 Gains (losses) on retained and sold ownership interests $ 628 $ 5,908 Other net interest and investment income (loss) 252 186 Licensing and royalty income 67 34 Equity method income 128 — Purchases and sales of business interests 9 (52) Other items 25 4 Total other income (loss) $ 1,109 $ 6,081

RESTRUCTURING CHARGES AND SEPAR

RESTRUCTURING CHARGES AND SEPARATION COSTS	3 Months Ended
RESTRUCTURING CHARGES AND SEPARATION COSTS	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
RESTRUCTURING CHARGES AND SEPARATION COSTS	NOTE 20. RESTRUCTURING CHARGES AND SEPARATION COSTS RESTRUCTURING AND OTHER CHARGES. This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. RESTRUCTURING AND OTHER CHARGES Three months ended March 31 2024 2023 Workforce reductions $ 141 $ 66 Plant closures & associated costs and other asset write-downs 85 82 Acquisition/disposition net charges and other 7 12 Total restructuring and other charges $ 233 $ 161 Cost of equipment/services $ 105 $ 36 Selling, general and administrative expenses 128 125 Total restructuring and other charges $ 233 $ 161 Aerospace $ 10 $ 4 Renewable Energy 96 65 Power 47 19 Corporate 80 72 Total restructuring and other charges(a) $ 233 $ 161 Restructuring and other charges cash expenditures(b) $ 154 $ 137 (a) Includes $125 million and $75 million, primarily in non-cash impairment, accelerated depreciation and other charges for the three months ended March 31, 2024 and 2023, respectively, not reflected in the liability table below. (b) Primarily for employee severance payments, contract and lease terminations. An analysis of changes in the liability for restructuring follows: Three months ended March 31 2024 2023 Balance at beginning of period $ 918 $ 977 Additions 108 86 Payments (137) (87) Effect of foreign currency and other (4) — Ending balance(a) $ 885 $ 976 (a) Includes actuarial determined post-employment severance benefits reserve of $325 million and $353 million as of March 31, 2024 and 2023, respectively. For the three months ended March 31, 2024 and 2023, respectively, restructuring primarily included exit activities related to the restructuring programs announced in 2022, reflecting lower Corporate shared-service and footprint needs as a result of the GE HealthCare spin-off, and exit activities across our businesses planned to be part of GE Vernova, primarily reflecting the selectivity strategy to operate in fewer markets and to simplify and standardize product variants at Renewable Energy. This plan was expanded during the third quarter of 2023 to include the consolidation of the global footprint and related resources at our Power business to better serve our customers. SEPARATION COSTS. In November 2021, the company announced its plan to form three industry-leading, global public companies focused on the growth sectors of aviation, healthcare, and energy. As a result of this plan, we have incurred and expect to continue to incur separation, transition, and operational costs, which will depend on specifics of the transactions. For the three months ended March 31, 2024 and 2023, respectively, we incurred $355 million and $205 million in pre-tax costs and paid $247 million and $204 million in cash, primarily related to employee costs, professional fees, costs to establish certain stand-alone functions and information technology systems, and other transformation and transaction costs to transition to stand-alone public companies. These costs are presented as separation costs in our consolidated Statement of Earnings (Loss). In addition, we recognized $54 million of net tax benefit and $56 million of net tax expense primarily associated with planned legal entity separation and tax on changes to indefinite reinvestment of foreign earnings. As discussed in Note 2, GE completed the separation of its HealthCare business into a separate, independent publicly traded company, GE HealthCare Technologies Inc. As a result, pre-tax separation costs specifically identifiable to GE HealthCare are now reflected in discontinued operations. We incurred zero and $20 million in pre-tax costs, recognized zero and $4 million of tax benefits, and spent $9 million and $85 million in cash related to GE HealthCare for the three months ended March 31, 2024 and 2023, respectively.

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS	3 Months Ended
FINANCIAL INSTRUMENTS	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
FINANCIAL INSTRUMENTS	NOTE 21. FINANCIAL INSTRUMENTS. The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. March 31, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,453 $ 2,333 $ 2,438 $ 2,379 Liabilities Borrowings (Note 11) $ 20,525 $ 20,037 $ 20,965 $ 20,689 Investment contracts (Note 13) 1,486 1,547 1,535 1,616 Assets and liabilities that are reflected in the accompanying financial statements at fair value are not included in the above disclosures; such items include cash and equivalents, investment securities and derivative financial instruments. DERIVATIVES AND HEDGING. Our policy requires that derivatives are used solely for managing risks and not for speculative purposes. We use derivatives to manage currency risks related to foreign exchange, and interest rate and currency risk between financial assets and liabilities, and certain equity investments and commodity prices. FAIR VALUE OF DERIVATIVES March 31, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 6,064 $ 161 $ 81 $ 6,648 $ 156 $ 91 Non-qualifying currency exchange contracts and other 48,981 717 477 50,563 794 580 Gross derivatives $ 55,045 $ 878 $ 558 $ 57,211 $ 950 $ 671 Netting and credit adjustments $ (434) $ (432) $ (512) $ (510) Net derivatives in statement of financial position $ 445 $ 126 $ 437 $ 161 FAIR VALUE HEDGES. As of March 31, 2024, all fair value hedges were terminated. Gains (losses) associated with the terminated hedging relationships will continue to amortize into interest expense until the hedged borrowings mature. The cumulative amount of hedging adjustments of $1,130 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $8,803 million. At March 31, 2023, the cumulative amount of hedging adjustments of $1,226 million (all on discontinued hedging relationships) was included in the carrying amount of the previously hedged liability of $8,817 million. The cumulative amount of hedging adjustments was primarily recorded in long-term borrowings CASH FLOW HEDGES AND NET INVESTMENT HEDGES Three months ended March 31 2024 2023 Cash flow hedges(a) $ 6 $ 28 Net investment hedges(b) 84 (62) (a) Primarily related to currency exchange contracts. (b) The carrying value of foreign currency debt designated as net investment hedges was $4,655 million and $3,398 million as of March 31, 2024 and 2023, respectively. The total reclassified from AOCI into earnings was zero and zero for the years ended March 31, 2024 and 2023, respectively. Changes in the fair value of cash flow hedges are recorded in AOCI and recorded in earnings in the period in which the hedged transaction occurs. The total amount in AOCI related to cash flow hedges of forecasted transactions was a $25 million loss as of March 31, 2024. We expect to reclassify $43 million of loss to earnings in the next 12 months contemporaneously with the earnings effects of the related forecasted transactions. As of March 31, 2024, the maximum term of derivative instruments that hedge forecasted transactions was approximately 12 years. The table below presents the effects of hedges and resulting gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss): Three months ended March 31, 2024 Three months ended March 31, 2023 Revenues Interest Expense SG&A Other(a) Revenues Interest Expense SG&A Other(a) $ 16,053 $ 278 $ 2,269 $ 12,729 $ 14,486 $ 269 $ 2,142 $ 16,810 Cash flow hedges $ 1 $ (2) $ — $ (4) $ 1 $ (2) $ — $ (2) Non-hedging derivatives (b) $ — $ — $ 43 $ (38) $ 2 $ — $ 115 $ (58) (a) Amounts are inclusive of cost of sales and other income (loss). (b) SG&A was primarily driven by hedges of deferred incentive compensation, and hedges of remeasurement of monetary assets and liabilities. COUNTERPARTY CREDIT RISK. Our exposures to counterparties were $381 million and $374 million at March 31, 2024 and December 31, 2023, respectively. Counterparties' exposures to our derivative liability were $80 million and $120 million at March 31, 2024 and December 31, 2023, respectively.

VARIABLE INTEREST ENTITIES

VARIABLE INTEREST ENTITIES	3 Months Ended
VARIABLE INTEREST ENTITIES	Mar. 31, 2024
Variable Interest Entities [Abstract]
VARIABLE INTEREST ENTITIES	NOTE 22. VARIABLE INTEREST ENTITIES. In our Statement of Financial Position, we have assets of $240 million and $117 million and liabilities of $262 million and $203 million at March 31, 2024 and December 31, 2023, respectively, in consolidated Variable Interest Entities (VIEs). These entities were created to help our customers facilitate or finance the purchase of GE equipment and services, and to manage our industrial insurance exposure through an insurance captive, and have no features that could expose us to losses that would significantly exceed the difference between the consolidated assets and liabilities.

COMMITMENTS, GUARANTEES, PRODUC

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES	NOTE 23. COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES COMMITMENTS. We had total investment commitments of $3,648 million and unfunded lending commitments, primarily at EFS, of $582 million at March 31, 2024. The investment commitments primarily comprise investments by our run-off insurance operations in other assets and investment securities of $3,570 million and included within these commitments are obligations to make investments in unconsolidated VIEs of $3,515 million. See Note 22 for further information. As of March 31, 2024, in our Aerospace segment, we have committed to provide financing assistance of $2,676 million of future customer acquisitions of aircraft equipped with our engines. GUARANTEES. Credit support. We have provided $909 million of credit support on behalf of certain customers or associated companies, predominantly joint ventures and partnerships, using arrangements such as standby letters of credit and performance guarantees, and a line of credit to support our consolidated subsidiaries. The liability for such credit support was $17 million. Indemnification agreements – Continuing Operations. GE has obligations under the Tax Matters Agreement to indemnify GE HealthCare for certain tax costs and other indemnifications of $35 million, which are fully reserved. In addition, we have $285 million of other indemnification commitments, including representations and warranties in sales of business assets, for which we recorded a liability of $71 million. Indemnification agreements - Discontinued Operations . Following the Separation of GE HealthCare on January 3, 2023, GE has remaining performance and bank guarantees on behalf of its former HealthCare business, with a maximum aggregate exposure of $25 million. GE also has obligations under the Transition Services Agreement and Tax Matters Agreement to indemnify GE HealthCare for certain technology and tax costs of $77 million, which are fully reserved. In addition, we have provided specific indemnities to other buyers of assets of our business that, in the aggregate, represent a maximum potential claim of $710 million with related reserves of $69 million. See Note 24 for further information on GE Vernova. PRODUCT WARRANTIES. We provide for estimated product warranty expenses when we sell the related products. Because warranty estimates are forecasts that are based on the best available information, mostly historical claims experience, claims costs may differ from amounts provided. The liability for product warranties was $1,999 million and $2,053 million at March 31, 2024 and December 31, 2023. LEGAL MATTERS. The following information supplements and amends the discussion of Legal Matters in Note 24 to the consolidated financial statements in our Annual Report on Form 10-K for the year ended December 31, 2023; refer to that discussion for information about previously reported legal matters that are not updated below. In the normal course of our business, we are involved from time to time in various arbitrations, class actions, commercial litigation, investigations and other legal, regulatory or governmental actions, including the significant matters described below that could have a material impact on our results of operations. In many proceedings, including the specific matters described below, it is inherently difficult to determine whether any loss is probable or even reasonably possible or to estimate the size or range of the possible loss, and accruals for legal matters are not recorded until a loss for a particular matter is considered probable and reasonably estimable. Given the nature of legal matters and the complexities involved, it is often difficult to predict and determine a meaningful estimate of loss or range of loss until we know, among other factors, the particular claims involved, the likelihood of success of our defenses to those claims, the damages or other relief sought, how discovery or other procedural considerations will affect the outcome, the settlement posture of other parties and other factors that may have a material effect on the outcome. For these matters, unless otherwise specified, we do not believe it is possible to provide a meaningful estimate of loss at this time. Moreover, it is not uncommon for legal matters to be resolved over many years, during which time relevant developments and new information must be continuously evaluated. Alstom legacy legal matters. In 2015, GE acquired the Steam Power, Renewables and Grid businesses from Alstom, which prior to our acquisition were the subject of significant cases involving anti-competitive activities and improper payments. We had reserves of $391 million and $393 million at March 31, 2024 and December 31, 2023, respectively, for legal and compliance matters related to the legacy business practices that were the subject of cases in various jurisdictions. Allegations in these cases relate to claimed anti-competitive conduct or improper payments in the pre-acquisition period as the source of legal violations or damages. Given the significant litigation and compliance activity related to these matters and the ongoing efforts to resolve them, it is difficult to assess whether the disbursements will ultimately be consistent with the reserve established. The estimation of this reserve may not reflect the full range of uncertainties and unpredictable outcomes inherent in litigation and investigations of this nature, and at this time we are unable to develop a meaningful estimate of the range of reasonably possible additional losses beyond the amount of this reserve. Factors that can affect the ultimate amount of losses associated with these and related matters include the way cooperation is assessed and valued, prosecutorial discretion in the determination of damages, formulas for determining disgorgement, fines or penalties, the duration and amount of legal and investigative resources applied, political and social influences within each jurisdiction, and tax consequences of any settlements or previous deductions, among other considerations. Actual losses arising from claims in these and related matters could exceed the amount provided. With the spin-off of GE Vernova on April 2, 2024, the liabilities associated with these matters transferred to GE Vernova. Shareholder and related lawsuits. Since November 2017, several putative shareholder class actions under the federal securities laws were filed against GE and certain affiliated individuals and consolidated into a single action currently pending in the U.S. District Court for the Southern District of New York (the Hachem case, also referred to as the Sjunde AP-Fonden case). The complaint against defendants GE and current and former GE executive officers alleged violations of Sections 10(b) and 20(a) and Rule 10b-5 of the Securities Exchange Act of 1934 related to insurance reserves and accounting for long-term service agreements and seeks damages on behalf of shareholders who acquired GE stock between February 27, 2013 and January 23, 2018. GE filed a motion to dismiss in December 2019. In January 2021, the court granted the motion to dismiss as to the majority of the claims. Specifically, the court dismissed all claims related to insurance reserves, as well as all claims related to accounting for long-term service agreements, with the exception of certain claims about historic disclosures related to factoring in the Power business that survive as to GE and its former CFO Jeffrey S. Bornstein. All other individual defendants have been dismissed from the case. In April 2022, the court granted the plaintiffs' motion for class certification for shareholders who acquired stock between February 26, 2016 and January 23, 2018. In September 2022, GE filed a motion for summary judgment on the plaintiffs' remaining claims, which the court denied in September 2023, except as to claims arising from disclosures made between November 2017 and January 2018. In April 2024, the court scheduled a trial date for November 2024. GE Retirement Savings Plan class actions . In 2017, four putative class action lawsuits were filed regarding the oversight of the GE RSP, and those class actions were consolidated into a single action in the U.S. District Court for the District of Massachusetts. The consolidated complaint named as defendants GE, GE Asset Management, current and former GE and GE Asset Management executive officers and employees who served on fiduciary bodies responsible for aspects of the GE RSP during the class period. Like similar lawsuits that were brought against other companies in recent years, this action alleged that the defendants breached their fiduciary duties under the Employee Retirement Income Security Act (ERISA) in their oversight of the GE RSP, principally by retaining five proprietary funds that plaintiffs alleged were underperforming as investment options for plan participants and by charging higher management fees than some alternative funds. The plaintiffs sought unspecified damages on behalf of a class of GE RSP participants and beneficiaries from September 26, 2011 through the date of any judgment. In March 2024, the court granted final approval of the previously reported class action settlement. Bank BPH . As previously reported, Bank BPH, along with other Polish banks, has been subject to ongoing litigation in Poland related to its portfolio of floating rate residential mortgage loans, with cases brought by individual borrowers seeking relief related to their foreign currency indexed or denominated mortgage loans in various courts throughout Poland. For a number of years, we have observed an increase in the total number of lawsuits being brought against Bank BPH and other banks in Poland by current and former borrowers, and we expect this to continue in future reporting periods. As previously reported, GE and Bank BPH approved the adoption of a settlement program and recorded an additional charge of $1,014 million in the quarter ended June 30, 2023. The estimate of total losses for borrower litigation at Bank BPH was $2,517 million and $2,669 million as of March 31, 2024 and December 31, 2023, respectively. The estimate accounts for the costs of payments to borrowers who we estimate will participate in the settlement program, as well as estimates for the results of litigation with other borrowers, which in either case can exceed the value of the current loan balance, and represents our best estimate of the total losses we expect to incur over time. However, there are a number of factors that could affect the estimate in the future; refer to the disclosure about Bank BPH in our Annual Report on Form 10-K for the year ended December 31, 2023. ENVIRONMENTAL, HEALTH AND SAFETY MATTERS . Our operations, like operations of other companies engaged in similar businesses, involve the use, disposal and cleanup of substances regulated under environmental protection laws and nuclear decommissioning regulations. We record reserves for obligations for ongoing and future environmental remediation activities, such as the Housatonic River cleanup, and for additional liabilities we expect to incur in connection with previously remediated sites, such as natural resource damages for the Hudson River where GE completed dredging in 2019. Additionally, like many other industrial companies, we and our subsidiaries are defendants in various lawsuits related to alleged exposure by workers and others to asbestos or other hazardous materials. Liabilities for environmental remediation, nuclear decommissioning and worker exposure claims exclude possible insurance recoveries. It is reasonably possible that our exposure will exceed amounts accrued. However, due to uncertainties about the status of laws, regulations, technology and information related to individual sites and lawsuits, such amounts are not reasonably estimable. Total reserves related to environmental remediation, nuclear decommissioning and worker exposure claims were $2,537 million and $2,465 million at March 31, 2024 and December 31, 2023, respectively.

SUBSEQUENT EVENT

SUBSEQUENT EVENT	3 Months Ended
SUBSEQUENT EVENT	Mar. 31, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENT	NOTE 24. SUBSEQUENT EVENT. On April 2, 2024 (the Distribution Date), GE completed the previously announced separation of its GE Vernova business, into a separate, independent publicly traded company, GE Vernova Inc. (GE Vernova). The separation was structured as a tax-free spin-off, and was achieved through GE's pro-rata distribution of all of the outstanding shares of GE Vernova to holders of GE common stock. On the Distribution Date, each holder of record of GE common stock received one share of GE Vernova common stock for every four shares of GE common stock held. As a result of the separation, GE Vernova became an independent public company that trades under the symbol “GEV” on the New York Stock Exchange and we will no longer consolidate GE Vernova into our financial results. In connection with the separation, the historical results of our Power, Renewable Energy and Digital businesses and certain assets and liabilities included in the separation will be reported in the Company's consolidated financial statements as discontinued operations beginning in the second quarter of 2024. Also in connection with the separation, the Company entered into various agreements to effect the separation and provide a framework for the relationship between it and GE Vernova, including a Separation and Distribution Agreement (SDA), a Tax Matters Agreement and a Transition Services Agreement (TSA). In connection with the separation and as a result of the legal split of certain plans as set forth in Note 13 in our Annual Report on Form 10-K for the year ended December 31, 2023, net liabilities of approximately $1.7 billion associated with GE's postretirement benefit plans, including a portion of the principal pension plans, the principal retiree benefit plans and other pension plans were transferred to GE Vernova. Deferred compensation arrangements and other compensation and benefits obligations of approximately $0.2 billion were also transferred to GE Vernova. The legal split and transfer of the plans and the related liabilities and obligations to GE Vernova will impact our assumptions and projections used to determine the funding and costs of the Company’s remaining plans. In connection with the separation, the Company contributed $0.5 billion of cash to fund GE Vernova’s future operations such that GE Vernova’s cash balance on the date of Separation was $4.2 billion, inclusive of $0.1 billion of cash reported in assets of businesses held for sale. Following the separation, the Company has remaining performance and bank guarantees on behalf of GE Vernova. To support GE Vernova in selling products and services globally, the Company often entered into contracts on behalf of GE Vernova or issued parent company guarantees or trade finance instruments supporting the performance of what were subsidiary legal entities transacting directly with customers, in addition to providing similar credit support for non-customer related activities of GE Vernova (collectively, “GE credit support”). Under the SDA, GE Vernova is obligated to use reasonable best efforts to replace the Company as the guarantor on or terminate all such credit support instruments. Until such termination or replacement, in the event of non-fulfillment of contractual obligations by the relevant obligor(s), the Company could be obligated to make payments under the applicable instruments. Under the SDA, GE Vernova is obligated to reimburse and indemnify the Company for any such payments. Beginning in 2025, GE Vernova will pay a quarterly fee to the Company based on amounts related to the GE credit support. The Company’s maximum aggregate exposure under the GE credit support cannot be reasonably estimated given the breadth of the portfolio across each of the GE Vernova businesses except for certain financial guarantees and trade finance instruments with a maximum exposure of approximately $1.5 billion, which are not expected to exceed a year beyond separation. The underlying obligations are predominantly customer contracts that GE Vernova performs in the normal course of its business. We have no known instances historically where payments or performance from the Company were required under parent company guarantees relating to GE Vernova customer contracts. The Company also has performance obligations related to GE Vernova's supply chain finance program and an environmental matter with a maximum aggregate exposure of $2.3 billion, of which $1.6 billion is not expected to exceed a year beyond separation. In addition, under the SDA, TSA, and TMA agreements, the Company also has an obligation to indemnify GE Vernova for certain of its technology costs, separation costs for certain facilities, severance costs, environmental matters and tax matters of approximately $0.6 billion.

SEGMENT OPERATIONS

SEGMENT OPERATIONS	3 Months Ended
SEGMENT OPERATIONS	Mar. 31, 2024
Segment Reporting [Abstract]
SEGMENT OPERATIONS	SEGMENT OPERATIONS. Refer to our Annual Report on Form 10-K for the year ended December 31, 2023, for further information regarding our determination of segment profit for continuing operations, and for our allocations of corporate costs to our segments. Three months ended March 31 SUMMARY OF REPORTABLE SEGMENTS 2024 2023 V % Aerospace $ 8,064 $ 6,981 16 % Renewable Energy 3,005 2,837 6 % Power 4,134 3,820 8 % Total segment revenues 15,203 13,638 11 % Corporate 850 848 — % Total revenues $ 16,053 $ 14,486 11 % Aerospace $ 1,529 $ 1,326 15 % Renewable Energy (226) (414) 45 % Power 229 75 F Total segment profit (loss) 1,532 987 55 % Corporate(a) 276 5,456 (95) % Interest and other financial charges (267) (257) (4) % Non-operating benefit income (cost) 362 385 (6) % Benefit (provision) for income taxes (380) (322) (18) % Preferred stock dividends — (145) F Earnings (loss) from continuing operations attributable to GE common shareholders 1,522 6,103 (75) % Earnings (loss) from discontinued operations attributable to GE common shareholders 14 1,257 (99) % Net earnings (loss) attributable to GE common shareholders $ 1,537 $ 7,360 (79) % (a) Includes interest and other financial charges of $10 million and $12 million; and benefit for income taxes of $62 million and $51 million related to Energy Financial Services (EFS) within Corporate for the three months ended March 31, 2024 and 2023 respectively.

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
FINANCIAL STATEMENT PRESENTATION	Our financial statements are prepared in conformity with U.S. generally accepted accounting principles (GAAP), which requires us to make estimates based on assumptions about current, and for some estimates, future, economic and market conditions, which affect reported amounts and related disclosures in our financial statements. Although our current estimates contemplate current and expected future conditions, as applicable, it is reasonably possible that actual conditions could differ from our expectations, which could materially affect our results of operations, financial position and cash flows. Such changes could result in future impairments of goodwill, intangibles, long-lived assets and investment securities, revisions to estimated profitability on long-term product service agreements, incremental credit losses on receivables and debt securities, a change in the carrying amount of our tax assets and liabilities, or a change in our insurance liabilities and pension obligations as of the time of a relevant measurement event. In preparing our Statement of Cash Flows, we make certain adjustments to reflect cash flows that cannot otherwise be calculated by changes in our Statement of Financial Position. These adjustments may include, but are not limited to, the effects of currency exchange, acquisitions and dispositions of businesses, businesses classified as held for sale, the timing of settlements to suppliers for property, plant and equipment, non-cash gains/losses and other balance sheet reclassifications.
RECLASSIFICATIONS	We have reclassified certain prior-year amounts to conform to the current-year’s presentation. Unless otherwise noted, tables are presented in U.S. dollars in millions. Certain columns and rows may not add due to the use of rounded numbers. Percentages presented are calculated from the underlying numbers in millions. Earnings per share amounts are computed independently for earnings from continuing operations, earnings from discontinued operations and net earnings. As a result, the sum of per-share amounts may not equal the total. Unless otherwise indicated, information in these notes to consolidated financial statements relates to continuing operations. Certain of our operations have been presented as discontinued. We present businesses whose disposal represents a strategic shift that has, or will have, a major effect on our operations and financial results as discontinued operations when the components meet the criteria for held for sale, are sold, or spun-off.

BUSINESSES HELD FOR SALE AND _2

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)	3 Months Ended
	Mar. 31, 2024
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Financial Information for Assets and Liabilities of Businesses Held for Sale	ASSETS AND LIABILITIES OF BUSINESSES HELD FOR SALE March 31, 2024 December 31, 2023 Cash and cash equivalents $ 88 $ 609 Current receivables, inventories and contract assets 633 551 Non-current captive insurance investment securities 548 570 Property, plant and equipment and intangible assets - net 253 254 Valuation allowance on disposal group classified as held for sale (124) (124) All other assets 108 125 Assets of businesses held for sale $ 1,507 $ 1,985 Progress collections and deferred income $ 964 $ 1,001 Insurance liabilities and annuity benefits 344 376 Accounts payable, equipment project payables and other current liabilities 463 392 All other liabilities 40 57 Liabilities of businesses held for sale $ 1,811 $ 1,826
Schedule of Financial Information for Discontinued Operations	2024 2023 RESULTS OF DISCONTINUED OPERATIONS Three months ended March 31 GE HealthCare Bank BPH & Other Total GE HealthCare Bank BPH & Other Total Total revenues $ — $ — $ — $ — $ — $ — Cost of equipment and services sold — — — — — — Other income, costs and expenses — 6 6 (20) (201) (221) Earnings (loss) of discontinued operations before income taxes — 6 6 (20) (201) (221) Benefit (provision) for income taxes — 6 6 1,479 (1) 1,478 Earnings (loss) of discontinued operations, net of taxes — 12 12 1,459 (202) 1,257 Gain (loss) on disposal before income taxes — 2 2 — — — Benefit (provision) for income taxes — — — — — — Gain (loss) on disposal, net of taxes — 2 2 — — — Earnings (loss) from discontinued operations, net of taxes $ — $ 14 $ 14 $ 1,459 $ (202) $ 1,257 The tax benefit for the three months ended March 31, 2023 for GE HealthCare relates to preparatory steps for the spin-off, which resulted in taxable gain offset by a deferred tax asset and the reversal of valuation allowances for capital loss carryovers utilized against a portion of the gain. ASSETS AND LIABILITIES OF DISCONTINUED OPERATIONS March 31, 2024 December 31, 2023 Cash, cash equivalents and restricted cash $ 1,391 $ 1,396 Current receivables 13 14 Property, plant and equipment - net 52 58 All other assets 224 200 Deferred income taxes 29 27 Assets of discontinued operations(a) $ 1,709 $ 1,695 Accounts payable and equipment project payables $ 34 $ 36 Non-current compensation and benefits 35 31 All other liabilities(a) 1,101 1,125 Liabilities of discontinued operations $ 1,169 $ 1,193

INVESTMENT SECURITIES (Tables)

INVESTMENT SECURITIES (Tables)	3 Months Ended
INVESTMENT SECURITIES (Tables)	Mar. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Schedule of Investment Securities	March 31, 2024 December 31, 2023 Amortized Gross Gross Estimated Amortized Gross Gross Estimated GE HealthCare equity $ — $ — $ — $ 2,776 $ — $ — $ — $ 4,761 AerCap note — — — 961 — — — 944 Current investment securities $ — $ — $ — $ 3,737 $ — $ — $ — $ 5,706 Debt U.S. corporate $ 27,477 $ 757 $ (1,870) $ 26,365 $ 27,495 $ 1,034 $ (1,606) $ 26,923 Non-U.S. corporate 2,509 26 (236) 2,299 2,529 34 (209) 2,353 State and municipal 2,803 54 (204) 2,654 2,828 79 (185) 2,723 Mortgage and asset-backed 4,878 36 (226) 4,688 4,827 34 (291) 4,571 Government and agencies 2,478 1 (125) 2,355 1,213 3 (116) 1,100 Other equity 344 — — 344 331 — — 331 Non-current investment securities $ 40,491 $ 875 $ (2,661) $ 38,705 $ 39,222 $ 1,183 $ (2,406) $ 38,000
Realized and Unrealized Gain (Loss) on Securities	Three months ended March 31 2024 2023 Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV) $ 441 $ 6,040 Proceeds from debt/equity securities sales and early redemptions 3,196 3,008 Gross realized gains on debt securities 8 11 Gross realized losses and impairments on debt securities (11) (21)
Contractual Maturities of Debt Securities (Excluding Mortgage and Asset-Backed Securities)	Contractual maturities of our debt securities (excluding mortgage and asset-backed securities) at March 31, 2024 are as follows: Amortized cost Estimated fair value Within one year $ 1,756 $ 1,751 After one year through five years 5,149 5,170 After five years through ten years 5,132 5,178 After ten years 23,231 21,574

CURRENT AND LONG-TERM RECEIVA_2

CURRENT AND LONG-TERM RECEIVABLES (Tables)	3 Months Ended
CURRENT AND LONG-TERM RECEIVABLES (Tables)	Mar. 31, 2024
Receivables [Abstract]
Schedule of Receivables and Allowance for Credit Losses	CURRENT RECEIVABLES March 31, 2024 December 31, 2023 Customer receivables $ 11,952 $ 12,349 Revenue sharing program receivables(a) 1,134 1,252 Non-income based tax receivables 1,225 1,140 Supplier advances 924 891 Receivables from disposed businesses 61 121 Other sundry receivables 450 360 Allowance for credit losses (646) (647) Total current receivables $ 15,100 $ 15,466 (a) Revenue sharing program receivables in Aerospace are amounts due from third parties who participate in engine programs by developing and supplying certain engine components through the life of the program. The participants share in program revenues, receive a share of customer progress payments and share costs related to discounts and warranties. ALLOWANCE FOR CREDIT LOSSES March 31, 2024 March 31, 2023 Balances as of January 1 $ 647 $ 768 New provisions, net of (releases) — 20 Write-offs, net — (4) Foreign exchange and other — 4 Ending balance $ 646 $ 787 March 31, 2024 December 31, 2023 Aerospace $ 7,848 $ 8,010 Renewable Energy 3,097 2,907 Power 4,332 4,232 Corporate(a) (177) 318 Total current receivables $ 15,100 $ 15,466 (a) Corporate balances include intercompany eliminations related to the sales of equipment and services. LONG-TERM RECEIVABLES March 31, 2024 December 31, 2023 Long-term customer receivables $ 459 $ 479 Supplier advances 271 274 Non-income based tax receivables 146 174 Sundry receivables 343 373 Allowance for credit losses (167) (171) Total long-term receivables $ 1,052 $ 1,129

INVENTORIES, INCLUDING DEFERR_2

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	3 Months Ended
INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Tables)	Mar. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Inventories	March 31, 2024 December 31, 2023 Raw materials and work in process $ 11,665 $ 11,209 Finished goods 3,952 3,720 Deferred inventory costs(a) 1,986 1,599 Inventories, including deferred inventory costs $ 17,603 $ 16,528

PROPERTY, PLANT AND EQUIPMENT_2

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	3 Months Ended
PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES (Tables)	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	March 31, 2024 December 31, 2023 Original cost $ 27,498 $ 27,332 Less: accumulated depreciation and amortization (16,935) (16,678) Right-of-use operating lease assets 1,782 1,840 Property, plant and equipment – net $ 12,345 $ 12,494

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	3 Months Ended
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Changes in Goodwill Balances	GOODWILL January 1, 2024 Acquisitions Currency exchange Balance at March 31, 2024 Aerospace $ 8,948 $ — $ (46) $ 8,902 Renewable Energy 3,287 — (34) 3,253 Power 307 4 (1) 311 Corporate(a) 842 — (4) 838 Total $ 13,385 $ 4 $ (84) $ 13,304

REVENUES (Tables)

REVENUES (Tables)	3 Months Ended
REVENUES (Tables)	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregated Revenues	EQUIPMENT & SERVICES REVENUES Three months ended March 31 2024 2023 Equipment Services Total Equipment Services Total Aerospace $ 2,421 $ 5,643 $ 8,064 $ 1,974 $ 5,007 $ 6,981 Renewable Energy 2,458 547 3,005 2,311 527 2,837 Power 1,185 2,949 4,134 1,102 2,718 3,820 Total segment revenues $ 6,064 $ 9,139 $ 15,203 $ 5,387 $ 8,252 $ 13,638 REVENUES Three months ended March 31 2024 2023 Commercial Engines and Services $ 6,064 $ 5,194 Defense and Propulsion Technologies 2,301 1,961 Eliminations & Other (301) (173) Aerospace(a) $ 8,064 $ 6,981 Onshore Wind $ 1,198 $ 1,502 Grid Solutions equipment and services 1,085 824 Hydro, Offshore Wind and Hybrid Solutions 722 511 Renewable Energy $ 3,005 $ 2,837 Gas Power $ 3,068 $ 2,867 Steam Power 584 541 Power Conversion, Nuclear and other 483 412 Power $ 4,134 $ 3,820 Total segment revenues $ 15,203 $ 13,638 GE Digital revenues $ 209 $ 237 Insurance revenues 879 791 Eliminations and other (237) (181) Corporate $ 850 $ 848 Total revenues $ 16,053 $ 14,486 (a) Does not give effect to post-GE Vernova separation eliminations and Corporate adjustments.

CONTRACT AND OTHER DEFERRED A_2

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME (Tables)	3 Months Ended
	Mar. 31, 2024
Contractors [Abstract]
Contract with Customer, Asset and Liability	March 31, 2024 Aerospace Renewable Energy Power Corporate Total Revenues in excess of billings $ 2,112 $ — $ 5,176 $ — $ 7,288 Billings in excess of revenues (7,965) — (1,794) — (9,759) Long-term service agreements $ (5,853) $ — $ 3,382 $ — $ (2,471) Equipment and other service agreements 603 1,628 1,506 281 4,018 Current contract assets $ (5,250) $ 1,628 $ 4,888 $ 281 $ 1,547 Nonrecurring engineering costs(a) 2,444 23 1 — 2,469 Customer advances and other(b) 2,353 — 609 — 2,963 Non-current contract and other deferred assets $ 4,798 $ 23 $ 611 $ — $ 5,431 Total contract and other deferred assets $ (452) $ 1,651 $ 5,499 $ 281 $ 6,978 December 31, 2023 Revenues in excess of billings $ 2,377 $ — $ 5,205 $ — $ 7,582 Billings in excess of revenues (7,902) — (1,810) — (9,712) Long-term service agreements $ (5,525) $ — $ 3,395 $ — $ (2,130) Equipment and other service agreements 494 1,374 1,499 263 3,630 Current contract assets $ (5,030) $ 1,374 $ 4,894 $ 263 $ 1,500 Nonrecurring engineering costs(a) 2,444 18 1 — 2,463 Customer advances and other(b) 2,342 — 601 — 2,943 Non-current contract and other deferred assets $ 4,785 $ 18 $ 603 $ — $ 5,406 Total contract and other deferred assets $ (245) $ 1,392 $ 5,497 $ 263 $ 6,907 (a) Included costs incurred prior to production (such as requisition engineering) for equipment production contracts, primarily within our Aerospace segment, which are amortized ratably over each unit produced. (b) Included amounts due from customers at Aerospace for the sales of engines, spare parts and services, and at Power, for the sale of services upgrades, which we collect through incremental fixed or usage-based fees from servicing the equipment under long-term service agreements. March 31, 2024 Aerospace Renewable Energy Power Corporate Total Progress collections $ 6,401 $ 7,554 $ 6,091 $ 134 $ 20,180 Current deferred income 179 221 11 127 539 Progress collections and current deferred income $ 6,580 $ 7,775 $ 6,103 $ 261 $ 20,718 Non-current deferred income 1,084 149 46 19 1,297 Total Progress collections and deferred income $ 7,664 $ 7,924 $ 6,148 $ 279 $ 22,016 December 31, 2023 Progress collections $ 6,198 $ 6,886 $ 5,898 $ 124 $ 19,106 Current deferred income 201 239 20 112 571 Progress collections and current deferred income $ 6,399 $ 7,125 $ 5,918 $ 236 $ 19,677 Non-current deferred income 1,150 122 48 20 1,339 Total Progress collections and deferred income $ 7,549 $ 7,247 $ 5,965 $ 256 $ 21,017

BORROWINGS (Tables)

BORROWINGS (Tables)	3 Months Ended
BORROWINGS (Tables)	Mar. 31, 2024
Debt Disclosure [Abstract]
Schedule of Borrowings	March 31, 2024 December 31, 2023 Current portion of long-term borrowings Senior notes $ 879 $ 1,044 Subordinated notes and other 81 107 Other short term borrowings 72 103 Total short-term borrowings $ 1,032 $ 1,253 Senior notes 17,351 $ 17,509 Subordinated notes 1,370 1,383 Other 772 819 Total long-term borrowings $ 19,493 $ 19,711 Total borrowings $ 20,525 $ 20,965

ACCOUNTS PAYABLE AND EQUIPMEN_2

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES (Tables)	3 Months Ended
ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES (Tables)	Mar. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accruals	March 31, 2024 December 31, 2023 Trade payables $ 10,486 $ 10,678 Supply chain finance programs 3,124 3,133 Equipment project payables(a) 1,117 1,193 Non-income based tax payables 456 403 Accounts payable and equipment project payables $ 15,184 $ 15,408 (a) Primarily related to projects at Power and Renewable Energy.

INSURANCE LIABILITIES AND ANN_2

INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	3 Months Ended
INSURANCE LIABILITIES AND ANNUITY BENEFITS (Tables)	Mar. 31, 2024
Insurance [Abstract]
Schedule of Insurance and Investment Contract Liabilities	A summary of our insurance liabilities and annuity benefits is presented below: March 31, 2024 Long-term care Structured settlement annuities Life Other contracts Total Future policy benefit reserves $ 25,722 $ 8,909 $ 1,054 $ 375 $ 36,059 Investment contracts — 776 — 710 1,486 Other — — 112 277 389 Total $ 25,722 $ 9,685 $ 1,166 $ 1,361 $ 37,934 December 31, 2023 Future policy benefit reserves $ 26,832 $ 9,357 $ 1,117 $ 382 $ 37,689 Investment contracts — 793 — 742 1,535 Other — — 116 285 400 Total $ 26,832 $ 10,150 $ 1,233 $ 1,409 $ 39,624
Summary of Future Policy Benefits	The following tables summarize balances of and changes in future policy benefits reserves. March 31, 2024 March 31, 2023 Present value of expected net premiums Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Balance, beginning of year $ 4,063 $ — $ 4,803 $ 4,059 $ — $ 4,828 Beginning balance at locked-in discount rate 3,745 — 4,773 3,958 — 5,210 Effect of changes in cash flow assumptions 17 — — — — — Effect of actual variances from expected experience 6 — (2) 29 — (35) Adjusted beginning of year balance 3,769 — 4,771 3,987 — 5,175 Interest accrual 51 — 45 53 — 50 Net premiums collected (98) — (70) (103) — (73) Effect of foreign currency — — (69) — — (23) Ending balance at locked-in discount rate 3,721 — 4,678 3,936 — 5,129 Effect of changes in discount rate assumptions 211 — (151) 281 — (149) Balance, end of period $ 3,932 $ — $ 4,527 $ 4,217 $ — $ 4,979 Present value of expected future policy benefits Balance, beginning of year $ 30,895 $ 9,357 $ 5,921 $ 28,316 $ 8,860 $ 5,868 Beginning balance at locked-in discount rate 27,144 8,561 5,847 27,026 8,790 6,247 Effect of changes in cash flow assumptions (7) — — (11) — — Effect of actual variances from expected experience 43 (29) (13) 30 (1) 2 Adjusted beginning of year balance 27,180 8,532 5,833 27,046 8,789 6,250 Interest accrual 368 111 55 363 115 60 Benefit payments (359) (159) (109) (309) (174) (138) Effect of foreign currency — — (73) — — (24) Ending balance at locked-in discount rate 27,190 8,484 5,707 27,100 8,730 6,148 Effect of changes in discount rate assumptions 2,465 425 (126) 3,171 619 (123) Balance, end of period $ 29,654 $ 8,909 $ 5,581 $ 30,271 $ 9,349 $ 6,025 Net future policy benefit reserves $ 25,722 $ 8,909 $ 1,054 $ 26,054 $ 9,349 $ 1,045 Less: Reinsurance recoverables, net of allowance for credit losses (165) — (29) (204) — (57) Net future policy benefit reserves, after reinsurance recoverables $ 25,557 $ 8,909 $ 1,025 $ 25,850 $ 9,349 $ 988 The following table provides the amount of undiscounted and discounted expected future gross premiums and expected future benefits and expenses for nonparticipating traditional contracts. March 31, 2024 March 31, 2023 Undiscounted Discounted(a) Undiscounted Discounted(a) Long-term care: Gross premiums $ 7,376 $ 4,794 $ 7,924 $ 5,105 Benefit payments 62,774 29,654 64,944 30,271 Structured settlement annuities: Benefit payments 19,092 8,909 19,745 9,349 Life: Gross premiums 12,082 5,446 13,537 6,104 Benefit payments 10,935 5,581 11,800 6,025 (a) Determined using the current discount rate as of March 31, 2024 and 2023, respectively. The following table provides the weighted-average durations of and weighted-average interest rates for the liability for future policy benefits. March 31, 2024 March 31, 2023 Long-term care Structured settlement annuities Life Long-term care Structured settlement annuities Life Duration (years)(a) 12.4 10.8 5.3 13.2 11.2 5.3 Interest accretion rate 5.6% 5.4% 5.2% 5.5% 5.4% 5.1% Current discount rate 5.2% 5.2% 5.0% 5.0% 5.0% 4.8%

POSTRETIREMENT BENEFIT PLANS (T

POSTRETIREMENT BENEFIT PLANS (Tables)	3 Months Ended
POSTRETIREMENT BENEFIT PLANS (Tables)	Mar. 31, 2024
Retirement Benefits [Abstract]
Schedule of Net Benefit Costs	The components of benefit plans cost other than the service cost are included in the caption Non-operating benefit costs in our Statement of Earnings (Loss). PRINCIPAL PENSION PLANS Three months ended March 31 2024 2023 Service cost for benefits earned $ 21 $ 21 Expected return on plan assets (578) (594) Interest cost on benefit obligations 453 474 Net actuarial loss amortization and other (152) (172) Net periodic expense (income) $ (256) $ (271)

SHAREHOLDERS' EQUITY (Tables)

SHAREHOLDERS' EQUITY (Tables)	3 Months Ended
SHAREHOLDERS' EQUITY (Tables)	Mar. 31, 2024
Equity [Abstract]
Schedule of Shareholders' Equity	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Three months ended March 31 (Dividends per share in dollars) 2024 2023 Beginning balance $ (3,623) $ (5,893) AOCI before reclasses – net of taxes of $26 and $(5) (35) 152 Reclasses from AOCI – net of taxes of $— and $(626)(a) — 2,234 AOCI (35) 2,387 Less AOCI attributable to noncontrolling interests — (1) Currency translation adjustments AOCI $ (3,658) $ (3,505) Beginning balance $ 1,786 $ 6,531 AOCI before reclasses – net of taxes of $8 and $(13) (29) (84) Reclasses from AOCI – net of taxes of $(52) and $(594)(a) (168) (2,235) AOCI (197) (2,319) Less AOCI attributable to noncontrolling interests 2 (2) Benefit plans AOCI $ 1,586 $ 4,214 Beginning balance $ (959) $ (1,927) AOCI before reclasses – net of taxes of $(116) and $188 (465) 718 Reclasses from AOCI – net of taxes of $0 and $0(a) 11 (12) AOCI (453) 706 Investment securities and cash flow hedges AOCI $ (1,412) $ (1,222) Beginning balance $ (3,354) $ (983) AOCI before reclasses – net of taxes of $328 and $(477) 1,236 (1,793) AOCI 1,236 (1,793) Long-duration insurance contracts AOCI $ (2,119) $ (2,776) AOCI at March 31 $ (5,603) $ (3,289) Dividends declared per common share $ — $ 0.08 (a) The total reclassification from AOCI included $195 million, including currency translation of $2,234 million and benefit plans of $(2,030) million, net of taxes, in first quarter of 2023 related to the spin-off of GE HealthCare.

EARNINGS PER SHARE INFORMATION

EARNINGS PER SHARE INFORMATION (Tables)	3 Months Ended
EARNINGS PER SHARE INFORMATION (Tables)	Mar. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share	Three months ended March 31 2024 2023 (Earnings for per-share calculation, shares in millions, per-share amounts in dollars) Diluted Basic Diluted Basic Earnings (loss) from continuing operations $ 1,522 $ 1,522 $ 6,242 $ 6,248 Preferred stock dividends and other and accretion of preferred share repurchase(a) — — (145) (145) Earnings (loss) from continuing operations attributable to common shareholders 1,522 1,522 6,097 6,103 Earnings (loss) from discontinued operations 14 14 1,257 1,257 Net earnings (loss) attributable to GE common shareholders 1,537 1,537 7,354 7,360 Shares of GE common stock outstanding 1,091 1,091 1,089 1,089 Employee compensation-related shares (including stock options) 11 — 8 — Total average equivalent shares 1,103 1,091 1,097 1,089 Earnings (loss) per share from continuing operations $ 1.38 $ 1.39 $ 5.56 $ 5.60 Earnings (loss) per share from discontinued operations 0.01 0.01 1.15 1.15 Net earnings (loss) per share 1.39 1.41 6.71 6.76 Potentially dilutive securities(b) 12 38 (a) For the three months ended March 31, 2023, included $(30) million related to excise tax on preferred share redemptions. (b) Outstanding stock awards not included in the computation of diluted earnings (loss) per share because their effect was antidilutive.

OTHER INCOME (LOSS) (Tables)

OTHER INCOME (LOSS) (Tables)	3 Months Ended
OTHER INCOME (LOSS) (Tables)	Mar. 31, 2024
Other Income and Expenses [Abstract]
Schedule of Other Income (Loss)	Three months ended March 31 2024 2023 Investment in GE HealthCare realized and unrealized gain (loss) $ 616 $ 6,093 Investment in and note with AerCap realized and unrealized gain (loss) 12 (195) Investment in Baker Hughes realized and unrealized gain (loss) — 10 Gains (losses) on retained and sold ownership interests $ 628 $ 5,908 Other net interest and investment income (loss) 252 186 Licensing and royalty income 67 34 Equity method income 128 — Purchases and sales of business interests 9 (52) Other items 25 4 Total other income (loss) $ 1,109 $ 6,081

RESTRUCTURING CHARGES AND SEP_2

RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	3 Months Ended
RESTRUCTURING CHARGES AND SEPARATION COSTS (Tables)	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	This table is inclusive of all restructuring charges in our segments and at Corporate, and the charges are shown below for the business where they originated. Separately, in our reported segment results, significant, higher-cost restructuring programs are excluded from measurement of segment operating performance for internal and external purposes; those excluded amounts are reported in Restructuring and other charges for Corporate. RESTRUCTURING AND OTHER CHARGES Three months ended March 31 2024 2023 Workforce reductions $ 141 $ 66 Plant closures & associated costs and other asset write-downs 85 82 Acquisition/disposition net charges and other 7 12 Total restructuring and other charges $ 233 $ 161 Cost of equipment/services $ 105 $ 36 Selling, general and administrative expenses 128 125 Total restructuring and other charges $ 233 $ 161 Aerospace $ 10 $ 4 Renewable Energy 96 65 Power 47 19 Corporate 80 72 Total restructuring and other charges(a) $ 233 $ 161 Restructuring and other charges cash expenditures(b) $ 154 $ 137 (a) Includes $125 million and $75 million, primarily in non-cash impairment, accelerated depreciation and other charges for the three months ended March 31, 2024 and 2023, respectively, not reflected in the liability table below. (b) Primarily for employee severance payments, contract and lease terminations. An analysis of changes in the liability for restructuring follows: Three months ended March 31 2024 2023 Balance at beginning of period $ 918 $ 977 Additions 108 86 Payments (137) (87) Effect of foreign currency and other (4) — Ending balance(a) $ 885 $ 976

FINANCIAL INSTRUMENTS (Tables)

FINANCIAL INSTRUMENTS (Tables)	3 Months Ended
FINANCIAL INSTRUMENTS (Tables)	Mar. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Estimated Fair Value of Assets and Liabilities	The following table provides information about assets and liabilities not carried at fair value and excludes finance leases, equity securities without readily determinable fair value and non-financial assets and liabilities. Substantially all of these assets are considered to be Level 3 and the vast majority of our liabilities’ fair value are considered Level 2. March 31, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Assets Loans and other receivables $ 2,453 $ 2,333 $ 2,438 $ 2,379 Liabilities Borrowings (Note 11) $ 20,525 $ 20,037 $ 20,965 $ 20,689 Investment contracts (Note 13) 1,486 1,547 1,535 1,616
Schedule of Fair Value of Derivative Assets	FAIR VALUE OF DERIVATIVES March 31, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 6,064 $ 161 $ 81 $ 6,648 $ 156 $ 91 Non-qualifying currency exchange contracts and other 48,981 717 477 50,563 794 580 Gross derivatives $ 55,045 $ 878 $ 558 $ 57,211 $ 950 $ 671 Netting and credit adjustments $ (434) $ (432) $ (512) $ (510) Net derivatives in statement of financial position $ 445 $ 126 $ 437 $ 161
Schedule of Fair Value of Derivative Liabilities	FAIR VALUE OF DERIVATIVES March 31, 2024 December 31, 2023 Gross Notional All other current assets All other current liabilities Gross Notional All other current assets All other current liabilities Qualifying currency exchange contracts $ 6,064 $ 161 $ 81 $ 6,648 $ 156 $ 91 Non-qualifying currency exchange contracts and other 48,981 717 477 50,563 794 580 Gross derivatives $ 55,045 $ 878 $ 558 $ 57,211 $ 950 $ 671 Netting and credit adjustments $ (434) $ (432) $ (512) $ (510) Net derivatives in statement of financial position $ 445 $ 126 $ 437 $ 161
Schedule of Effects of Derivatives on AOCI	CASH FLOW HEDGES AND NET INVESTMENT HEDGES Three months ended March 31 2024 2023 Cash flow hedges(a) $ 6 $ 28 Net investment hedges(b) 84 (62) (a) Primarily related to currency exchange contracts. (b) The carrying value of foreign currency debt designated as net investment hedges was $4,655 million and $3,398 million as of March 31, 2024 and 2023, respectively. The total reclassified from AOCI into earnings was zero and zero for the years ended March 31, 2024 and 2023, respectively.
Schedule of Effects of Derivatives on Earnings	The table below presents the effects of hedges and resulting gains (losses) of our derivative financial instruments in the Statement of Earnings (Loss): Three months ended March 31, 2024 Three months ended March 31, 2023 Revenues Interest Expense SG&A Other(a) Revenues Interest Expense SG&A Other(a) $ 16,053 $ 278 $ 2,269 $ 12,729 $ 14,486 $ 269 $ 2,142 $ 16,810 Cash flow hedges $ 1 $ (2) $ — $ (4) $ 1 $ (2) $ — $ (2) Non-hedging derivatives (b) $ — $ — $ 43 $ (38) $ 2 $ — $ 115 $ (58) (a) Amounts are inclusive of cost of sales and other income (loss). (b) SG&A was primarily driven by hedges of deferred incentive compensation, and hedges of remeasurement of monetary assets and liabilities.

SEGMENT OPERATIONS (Tables)

SEGMENT OPERATIONS (Tables)	3 Months Ended
SEGMENT OPERATIONS (Tables)	Mar. 31, 2024
Segment Reporting [Abstract]
Summary of Operating Segments	Three months ended March 31 SUMMARY OF REPORTABLE SEGMENTS 2024 2023 V % Aerospace $ 8,064 $ 6,981 16 % Renewable Energy 3,005 2,837 6 % Power 4,134 3,820 8 % Total segment revenues 15,203 13,638 11 % Corporate 850 848 — % Total revenues $ 16,053 $ 14,486 11 % Aerospace $ 1,529 $ 1,326 15 % Renewable Energy (226) (414) 45 % Power 229 75 F Total segment profit (loss) 1,532 987 55 % Corporate(a) 276 5,456 (95) % Interest and other financial charges (267) (257) (4) % Non-operating benefit income (cost) 362 385 (6) % Benefit (provision) for income taxes (380) (322) (18) % Preferred stock dividends — (145) F Earnings (loss) from continuing operations attributable to GE common shareholders 1,522 6,103 (75) % Earnings (loss) from discontinued operations attributable to GE common shareholders 14 1,257 (99) % Net earnings (loss) attributable to GE common shareholders $ 1,537 $ 7,360 (79) % (a) Includes interest and other financial charges of $10 million and $12 million; and benefit for income taxes of $62 million and $51 million related to Energy Financial Services (EFS) within Corporate for the three months ended March 31, 2024 and 2023 respectively.

BUSINESSES HELD FOR SALE AND _3

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Assets Held for Sale Narrative (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of businesses held for sale	$ 1,507	$ 1,985
Liabilities of businesses held for sale	1,811	$ 1,826
Electric Insurance Company
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Assets of businesses held for sale	514
Liabilities of businesses held for sale	339
Pre-tax loss on sale	$ 126

BUSINESSES HELD FOR SALE AND _4

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Assets and Liabilities of Businesses Held for Sale (Details) - Held for sale, not discontinued operation - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Assets
Cash and cash equivalents	$ 88	$ 609
Current receivables, inventories and contract assets	633	551
Non-current captive insurance investment securities	548	570
Property, plant and equipment and intangible assets - net	253	254
Valuation allowance on disposal group classified as held for sale	(124)	(124)
All other assets	108	125
Assets of discontinued operations	1,507	1,985
Liabilities
Progress collections and deferred income	964	1,001
Insurance liabilities and annuity benefits	344	376
Accounts payable, equipment project payables and other current liabilities	463	392
All other liabilities	40	57
Liabilities of discontinued operations	$ 1,811	$ 1,826

BUSINESSES HELD FOR SALE AND _5

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Discontinued Operations Narrative (Details) - USD ($)		3 Months Ended
	Jan. 03, 2023	Mar. 31, 2024	Jun. 30, 2023	Mar. 31, 2023
Spinoff \| GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Ownership interest disposed of	80.10%
Discontinued operations after disposal, cash collected (paid)		$ 115,000,000
Discontinued operations \| Bank BPH
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Pre-tax non-cash charges		0	$ 1,014,000,000	$ 175,000,000
Capital contribution, non-cash		1,797,000,000
Financing receivables held for sale		$ 0

BUSINESSES HELD FOR SALE AND _6

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
RESULTS OF DISCONTINUED OPERATIONS
Earnings (loss) from discontinued operations, net of taxes	$ 14	$ 1,257
Discontinued operations
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0
Cost of equipment and services sold	0	0
Other income, costs and expenses	6	(221)
Earnings (loss) of discontinued operations before income taxes	6	(221)
Benefit (provision) for income taxes	6	1,478
Earnings (loss) of discontinued operations, net of taxes	12	1,257
Gain (loss) on disposal before income taxes	2	0
Benefit (provision) for income taxes	0	0
Gain (loss) on disposal, net of taxes	2	0
Earnings (loss) from discontinued operations, net of taxes	14	1,257
Assets
Cash, cash equivalents and restricted cash	1,391		$ 1,396
Current receivables	13		14
Property, plant and equipment - net	52		58
All other assets	224		200
Deferred income taxes	29		27
Assets of discontinued operations	1,709		1,695
Liabilities
Accounts payable and equipment project payables	34		36
Non-current compensation and benefits	35		31
All other liabilities	1,101		1,125
Liabilities of discontinued operations	1,169		$ 1,193
Discontinued operations \| GE HealthCare
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0
Cost of equipment and services sold	0	0
Other income, costs and expenses	0	(20)
Earnings (loss) of discontinued operations before income taxes	0	(20)
Benefit (provision) for income taxes	0	1,479
Earnings (loss) of discontinued operations, net of taxes	0	1,459
Gain (loss) on disposal before income taxes	0	0
Benefit (provision) for income taxes	0	0
Gain (loss) on disposal, net of taxes	0	0
Earnings (loss) from discontinued operations, net of taxes	0	1,459
Discontinued operations \| Bank BPH & Other
RESULTS OF DISCONTINUED OPERATIONS
Total revenues	0	0
Cost of equipment and services sold	0	0
Other income, costs and expenses	6	(201)
Earnings (loss) of discontinued operations before income taxes	6	(201)
Benefit (provision) for income taxes	6	(1)
Earnings (loss) of discontinued operations, net of taxes	12	(202)
Gain (loss) on disposal before income taxes	2	0
Benefit (provision) for income taxes	0	0
Gain (loss) on disposal, net of taxes	2	0
Earnings (loss) from discontinued operations, net of taxes	$ 14	$ (202)

BUSINESSES HELD FOR SALE AND _7

BUSINESSES HELD FOR SALE AND DISCONTINUED OPERATIONS - Financial Information for Discontinued Operations - Footnote (Details) - Discontinued operations - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance on finance receivables classified as held for sale	$ 1,792	$ 1,963
All other liabilities	1,101	1,125
Bank BPH \| Bank BPH litigation
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Valuation allowance on finance receivables classified as held for sale	1,553	1,712
All other liabilities	964	957
Estimated borrower litigation losses	$ 2,517	$ 2,669

INVESTMENT SECURITIES - Narrati

INVESTMENT SECURITIES - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Accrued interest, current	$ 496		$ 466
Accrued interest, current, statement of financial position	All other current assets (Note 10)		All other current assets (Note 10)
Debt securities in unrealized loss position, total	$ 20,413		$ 18,730
Debt securities in unrealized loss position, 12 months or more	16,711		17,146
Gross unrealized losses, 12 months or more	(2,584)		(2,370)
Gross unrealized losses	(2,661)		(2,406)
Investments without readily determinable fair value	1,092		1,012
Fair value adjustments, including impairment	23	$ 9
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment securities	6,991		6,841
CMBS
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(149)
Asset-backed securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Gross unrealized losses	(68)
Insurance
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investments without readily determinable fair value	$ 1,019		$ 939
GE HealthCare
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Equity securities, investment interest (in shares)	30.5
Equity securities, ownership percentage	6.70%

INVESTMENT SECURITIES - Schedul

INVESTMENT SECURITIES - Schedule of Investment Securities (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	$ 0	$ 0
Estimated fair value	3,737	5,706
Gross unrealized gains	875	1,183
Gross unrealized losses	(2,661)	(2,406)
Other equity	344	331
Non-current investment securities, amortized cost	40,491	39,222
Non-current investment securities, estimated fair value	38,705	38,000
U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	27,477	27,495
Gross unrealized gains	757	1,034
Gross unrealized losses	(1,870)	(1,606)
Estimated fair value	26,365	26,923
Non-U.S. corporate
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,509	2,529
Gross unrealized gains	26	34
Gross unrealized losses	(236)	(209)
Estimated fair value	2,299	2,353
State and municipal
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,803	2,828
Gross unrealized gains	54	79
Gross unrealized losses	(204)	(185)
Estimated fair value	2,654	2,723
Mortgage and asset-backed
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	4,878	4,827
Gross unrealized gains	36	34
Gross unrealized losses	(226)	(291)
Estimated fair value	4,688	4,571
Government and agencies
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost, excluding accrued interest	2,478	1,213
Gross unrealized gains	1	3
Gross unrealized losses	(125)	(116)
Estimated fair value	2,355	1,100
GE HealthCare
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	0	0
Estimated fair value	2,776	4,761
AerCap
Debt and Equity Securities, FV-NI [Line Items]
Amortized cost	0	0
Estimated fair value	$ 961	$ 944

INVESTMENT SECURITIES - Realize

INVESTMENT SECURITIES - Realized and Unrealized Gain (Loss) on Securities (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Net unrealized gains (losses) for equity securities with readily determinable fair value (RDFV)	$ 441	$ 6,040
Proceeds from debt/equity securities sales and early redemptions	3,196	3,008
Gross realized gains on debt securities	8	11
Gross realized losses and impairments on debt securities	$ (11)	$ (21)

INVESTMENT SECURITIES - Contrac

INVESTMENT SECURITIES - Contractual Maturities (Details) $ in Millions	Mar. 31, 2024 USD ($)
Amortized cost
Within one year	$ 1,756
After one year through five years	5,149
After five years through ten years	5,132
After ten years	23,231
Estimated fair value
Within one year	1,751
After one year through five years	5,170
After five years through ten years	5,178
After ten years	$ 21,574

CURRENT AND LONG-TERM RECEIVA_3

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Current Receivables (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023	Dec. 31, 2022
Accounts, Notes, Loans and Financing Receivable [Line Items]
Customer receivables	$ 11,952	$ 12,349
Revenue sharing program receivables	1,134	1,252
Non-income based tax receivables	1,225	1,140
Supplier advances	924	891
Receivables from disposed businesses	61	121
Other sundry receivables	450	360
Allowance for credit losses	(646)	(647)	$ (787)	$ (768)
Total current receivables	15,100	15,466
Operating segments \| Aerospace
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	7,848	8,010
Operating segments \| Renewable Energy
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	3,097	2,907
Operating segments \| Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	4,332	4,232
Corporate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total current receivables	$ (177)	$ 318

CURRENT AND LONG-TERM RECEIVA_4

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Allowance for Credit Losses (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Allowance For Credit Losses [Roll Forward]
Balances as of January 1	$ 647	$ 768
New provisions, net of (releases)	0	20
Write-offs, net	0	(4)
Foreign exchange and other	0	4
Ending balance	$ 646	$ 787

CURRENT AND LONG-TERM RECEIVA_5

CURRENT AND LONG-TERM RECEIVABLES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Sale of current customer receivables	$ 306	$ 464
Gas Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Sale of current customer receivables		$ 77

CURRENT AND LONG-TERM RECEIVA_6

CURRENT AND LONG-TERM RECEIVABLES - Schedule of Long-term Receivables (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Receivables [Abstract]
Long-term customer receivables	$ 459	$ 479
Supplier advances	271	274
Non-income based tax receivables	146	174
Sundry receivables	343	373
Allowance for credit losses	(167)	(171)
Total long-term receivables	$ 1,052	$ 1,129

INVENTORIES, INCLUDING DEFERR_3

INVENTORIES, INCLUDING DEFERRED INVENTORY COSTS (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and work in process	$ 11,665	$ 11,209
Finished goods	3,952	3,720
Deferred inventory costs	1,986	1,599
Inventories, including deferred inventory costs	$ 17,603	$ 16,528

PROPERTY, PLANT AND EQUIPMENT_3

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Schedule of Property, Plant and Equipment (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Original cost	$ 27,498	$ 27,332
Less: accumulated depreciation and amortization	(16,935)	(16,678)
Right-of-use operating lease assets	1,782	1,840
Property, plant and equipment – net	$ 12,345	$ 12,494
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment – net	Property, plant and equipment – net

PROPERTY, PLANT AND EQUIPMENT_4

PROPERTY, PLANT AND EQUIPMENT AND OPERATING LEASES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Property, Plant and Equipment [Abstract]
Operating lease liabilities	$ 1,908		$ 1,973
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	All other liabilities (Note 15)		All other liabilities (Note 15)
Long-term (fixed)	$ 188	$ 195

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS - Changes in Goodwill Balances (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill
Balance at beginning of period	$ 13,385
Acquisitions	4
Currency exchange and other	(84)
Balance at end of period	13,304
Operating segments \| Aerospace
Goodwill
Balance at beginning of period	8,948
Acquisitions	0
Currency exchange and other	(46)
Balance at end of period	8,902
Operating segments \| Renewable Energy
Goodwill
Balance at beginning of period	3,287
Acquisitions	0
Currency exchange and other	(34)
Balance at end of period	3,253
Operating segments \| Power
Goodwill
Balance at beginning of period	307
Acquisitions	4
Currency exchange and other	(1)
Balance at end of period	311
Corporate, non-segment
Goodwill
Balance at beginning of period	842
Acquisitions	0
Currency exchange and other	(4)
Balance at end of period	$ 838

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Goodwill [Line Items]
Goodwill	$ 13,304		$ 13,385
Increase (decrease) in intangible assets	(148)
Amortization of intangible assets	145	$ 140
Operating segments \| Aerospace
Goodwill [Line Items]
Goodwill	8,902		$ 8,948
Operating segments \| Additive \| Aerospace
Goodwill [Line Items]
Goodwill	$ 244

REVENUES - Schedule of Disaggre

REVENUES - Schedule of Disaggregated Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 16,053	$ 14,486
Operating segments
Disaggregation of Revenue [Line Items]
Revenues	15,203	13,638
Operating segments \| Equipment
Disaggregation of Revenue [Line Items]
Revenues	6,064	5,387
Operating segments \| Services
Disaggregation of Revenue [Line Items]
Revenues	9,139	8,252
Operating segments \| Aerospace
Disaggregation of Revenue [Line Items]
Revenues	8,064	6,981
Operating segments \| Aerospace \| Equipment
Disaggregation of Revenue [Line Items]
Revenues	2,421	1,974
Operating segments \| Aerospace \| Services
Disaggregation of Revenue [Line Items]
Revenues	5,643	5,007
Operating segments \| Aerospace \| Commercial Engines and Services
Disaggregation of Revenue [Line Items]
Revenues	6,064	5,194
Operating segments \| Aerospace \| Defense and Propulsion Technologies
Disaggregation of Revenue [Line Items]
Revenues	2,301	1,961
Operating segments \| Aerospace \| Eliminations & Other
Disaggregation of Revenue [Line Items]
Revenues	(301)	(173)
Operating segments \| Renewable Energy
Disaggregation of Revenue [Line Items]
Revenues	3,005	2,837
Operating segments \| Renewable Energy \| Equipment
Disaggregation of Revenue [Line Items]
Revenues	2,458	2,311
Operating segments \| Renewable Energy \| Services
Disaggregation of Revenue [Line Items]
Revenues	547	527
Operating segments \| Renewable Energy \| Onshore Wind
Disaggregation of Revenue [Line Items]
Revenues	1,198	1,502
Operating segments \| Renewable Energy \| Grid Solutions equipment and services
Disaggregation of Revenue [Line Items]
Revenues	1,085	824
Operating segments \| Renewable Energy \| Hydro, Offshore Wind and Hybrid Solutions
Disaggregation of Revenue [Line Items]
Revenues	722	511
Operating segments \| Power
Disaggregation of Revenue [Line Items]
Revenues	4,134	3,820
Operating segments \| Power \| Equipment
Disaggregation of Revenue [Line Items]
Revenues	1,185	1,102
Operating segments \| Power \| Services
Disaggregation of Revenue [Line Items]
Revenues	2,949	2,718
Operating segments \| Power \| Gas Power
Disaggregation of Revenue [Line Items]
Revenues	3,068	2,867
Operating segments \| Power \| Steam Power
Disaggregation of Revenue [Line Items]
Revenues	584	541
Operating segments \| Power \| Power Conversion, Nuclear and other
Disaggregation of Revenue [Line Items]
Revenues	483	412
Corporate
Disaggregation of Revenue [Line Items]
Revenues	850	848
Corporate, non-segment \| GE Digital revenues
Disaggregation of Revenue [Line Items]
Revenues	209	237
Corporate, non-segment \| Insurance revenues
Disaggregation of Revenue [Line Items]
Revenues	879	791
Eliminations and other
Disaggregation of Revenue [Line Items]
Revenues	$ (237)	$ (181)

REVENUES - Remaining Performanc

REVENUES - Remaining Performance Obligation (Details) $ in Millions	Mar. 31, 2024 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 265,870
Equipment
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 57,775
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	41%
Performance obligations expected to be satisfied, expected timing	1 year
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	65%
Performance obligations expected to be satisfied, expected timing	2 years
Equipment \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	88%
Performance obligations expected to be satisfied, expected timing	5 years
Services
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligations expected to be satisfied	$ 208,095
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period one
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	13%
Performance obligations expected to be satisfied, expected timing	1 year
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period two
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	46%
Performance obligations expected to be satisfied, expected timing	5 years
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period three
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	69%
Performance obligations expected to be satisfied, expected timing	10 years
Services \| Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01 \| Performance obligation satisfaction, period four
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Performance obligation expected to be satisfied (as a percent)	84%
Performance obligations expected to be satisfied, expected timing	15 years

CONTRACT AND OTHER DEFERRED A_3

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Capitalized Contract Cost [Line Items]
Increase in contract and other deferred assets	$ 72
Increase in progress collections and deferred income due to timing of revenue recognition	999
Revenue recognized included in contract liability	4,628	$ 4,468
Long-term
Capitalized Contract Cost [Line Items]
Increase (decrease) due to billings	(3,155)
Revenues recognized	3,029
Long-term \| Power
Capitalized Contract Cost [Line Items]
Net favorable (unfavorable) change in estimated profitability	(29)
Long-term \| Aerospace
Capitalized Contract Cost [Line Items]
Net favorable (unfavorable) change in estimated profitability	$ (162)

CONTRACT AND OTHER DEFERRED A_4

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Schedule of Contract Assets (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	$ 7,288	$ 7,582
Billings in excess of revenues	(9,759)	(9,712)
Long-term service agreements	(2,471)	(2,130)
Equipment and other service agreements	4,018	3,630
Current contract assets	1,547	1,500
Nonrecurring engineering costs	2,469	2,463
Customer advances and other	2,963	2,943
Non-current contract and other deferred assets	5,431	5,406
Total contract and other deferred assets	6,978	6,907
Operating segments \| Aerospace
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	2,112	2,377
Billings in excess of revenues	(7,965)	(7,902)
Long-term service agreements	(5,853)	(5,525)
Equipment and other service agreements	603	494
Current contract assets	(5,250)	(5,030)
Nonrecurring engineering costs	2,444	2,444
Customer advances and other	2,353	2,342
Non-current contract and other deferred assets	4,798	4,785
Total contract and other deferred assets	(452)	(245)
Operating segments \| Renewable Energy
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Equipment and other service agreements	1,628	1,374
Current contract assets	1,628	1,374
Nonrecurring engineering costs	23	18
Customer advances and other	0	0
Non-current contract and other deferred assets	23	18
Total contract and other deferred assets	1,651	1,392
Operating segments \| Power
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	5,176	5,205
Billings in excess of revenues	(1,794)	(1,810)
Long-term service agreements	3,382	3,395
Equipment and other service agreements	1,506	1,499
Current contract assets	4,888	4,894
Nonrecurring engineering costs	1	1
Customer advances and other	609	601
Non-current contract and other deferred assets	611	603
Total contract and other deferred assets	5,499	5,497
Corporate
Accounts, Notes, Loans and Financing Receivable [Line Items]
Revenues in excess of billings	0	0
Billings in excess of revenues	0	0
Long-term service agreements	0	0
Equipment and other service agreements	281	263
Current contract assets	281	263
Nonrecurring engineering costs	0	0
Customer advances and other	0	0
Non-current contract and other deferred assets	0	0
Total contract and other deferred assets	$ 281	$ 263

CONTRACT AND OTHER DEFERRED A_5

CONTRACT AND OTHER DEFERRED ASSETS & PROGRESS COLLECTIONS AND DEFERRED INCOME - Progress Collections and Deferred Income (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Capitalized Contract Cost [Line Items]
Progress collections	$ 20,180	$ 19,106
Current deferred income	539	571
Progress collections and current deferred income	20,718	19,677
Non-current deferred income	1,297	1,339
Total Progress collections and deferred income	22,016	21,017
Operating segments \| Aerospace
Capitalized Contract Cost [Line Items]
Progress collections	6,401	6,198
Current deferred income	179	201
Progress collections and current deferred income	6,580	6,399
Non-current deferred income	1,084	1,150
Total Progress collections and deferred income	7,664	7,549
Operating segments \| Renewable Energy
Capitalized Contract Cost [Line Items]
Progress collections	7,554	6,886
Current deferred income	221	239
Progress collections and current deferred income	7,775	7,125
Non-current deferred income	149	122
Total Progress collections and deferred income	7,924	7,247
Operating segments \| Power
Capitalized Contract Cost [Line Items]
Progress collections	6,091	5,898
Current deferred income	11	20
Progress collections and current deferred income	6,103	5,918
Non-current deferred income	46	48
Total Progress collections and deferred income	6,148	5,965
Corporate
Capitalized Contract Cost [Line Items]
Progress collections	134	124
Current deferred income	127	112
Progress collections and current deferred income	261	236
Non-current deferred income	19	20
Total Progress collections and deferred income	$ 279	$ 256

ALL OTHER ASSETS (Details)

ALL OTHER ASSETS (Details) - USD ($) $ in Millions	3 Months Ended
ALL OTHER ASSETS (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Increase (decrease) in other non-current assets	$ 999
Increase (decrease) in insurance cash and cash equivalents	581
Increase (decrease) in equity method and other investments	229
Increase (decrease) in prepaid taxes and deferred charges	179
Insurance cash and cash equivalents	$ 1,364	$ 784

BORROWINGS (Details)

BORROWINGS (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total short-term borrowings	$ 1,032	$ 1,253
Long-term borrowings and lease obligation	19,493	19,711
Total borrowings	20,525	20,965
Senior notes
Debt Instrument [Line Items]
Long-term borrowings	17,351	17,509
Subordinated notes and other
Debt Instrument [Line Items]
Long-term borrowings	1,370	1,383
Other
Debt Instrument [Line Items]
Long-term borrowings and lease obligation	772	819
Senior notes
Debt Instrument [Line Items]
Current portion of long-term borrowings	879	1,044
Subordinated notes and other
Debt Instrument [Line Items]
Current portion of long-term borrowings	81	107
Other short term borrowings
Debt Instrument [Line Items]
Other short term borrowings	$ 72	$ 103

ACCOUNTS PAYABLE AND EQUIPMEN_3

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYABLES - Schedule of Accounts Payable and Accruals (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Payables and Accruals [Abstract]
Trade payables	$ 10,486	$ 10,678
Supply chain finance programs	3,124	3,133
Equipment project payables	1,117	1,193
Non-income based tax payables	456	403
Accounts payable and equipment project payables	$ 15,184	$ 15,408

ACCOUNTS PAYABLE AND EQUIPMEN_4

ACCOUNTS PAYABLE AND EQUIPMENT PROJECT PAYBLES - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Payables and Accruals [Abstract]
Supplier finance program, invoices paid	$ 1,705	$ 2,079

INSURANCE LIABILITIES AND ANN_3

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Narrative (Details) $ in Millions	3 Months Ended		63 Months Ended
	Mar. 31, 2024 USD ($) loan	Mar. 31, 2023 USD ($)	Mar. 31, 2024 USD ($) loan	Dec. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Insurance revenues	$ 879	$ 791
Net earnings (loss)	$ 1,563	7,478
Percent of portfolio held in office sector	33.30%		33.30%
Gross premium income	$ 207	214
Interest accretion	439	435
Policyholder account balance	1,686	1,921	$ 1,686
Policyholder account balance, surrender, withdrawal and benefit payments	106	120
Policyholder account balance, net additions and interest credited	66	75
Capital contributions to insurance subsidiaries	$ 1,820		$ 15,035
Minimum
Disaggregation of Revenue [Line Items]
Policyholder account balance, crediting rate	3%		3%	3%
Maximum
Disaggregation of Revenue [Line Items]
Policyholder account balance, crediting rate	6%		6%	6%
Long-term care
Disaggregation of Revenue [Line Items]
Gross premium income	$ 123	124
Interest accretion	318	310
Life
Disaggregation of Revenue [Line Items]
Gross premium income	79	84
Structured settlement annuities
Disaggregation of Revenue [Line Items]
Interest accretion	111	115
Run-off insurance operations
Disaggregation of Revenue [Line Items]
Insurance revenues	879	791
Gross profit (loss)	200	70
Net earnings (loss)	158	$ 54
Investment securities	38,304		$ 38,304	$ 37,592
Limited partnerships	3,498		3,498	3,300
Run-off insurance operations \| CMBS
Disaggregation of Revenue [Line Items]
Debt securities, net	1,924		1,924	1,947
Debt securities, allowance for credit losses	$ 61		$ 61	$ 48
Number of delinquent loans \| loan	4		4
Number of nonaccrual loans \| loan	1		1
Weighted average loan to value ratio	70%		70%
Debt service coverage ratio	1.6		1.6

INSURANCE LIABILITIES AND ANN_4

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Schedule of Investment Contracts, Insurance Liabilities and Insurance Annuity Benefits (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	$ 36,059	$ 37,689
Investment contracts	1,486	1,535
Other	389	400
Total	37,934	39,624
Long-term care
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	25,722	26,832	$ 26,054
Investment contracts	0	0
Other	0	0
Total	25,722	26,832
Structured settlement annuities
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	8,909	9,357	9,349
Investment contracts	776	793
Other	0	0
Total	9,685	10,150
Life
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	1,054	1,117	$ 1,045
Investment contracts	0	0
Other	112	116
Total	1,166	1,233
Other contracts
Liability for Future Policy Benefit, Activity [Line Items]
Future policy benefit reserves	375	382
Investment contracts	710	742
Other	277	285
Total	$ 1,361	$ 1,409

INSURANCE LIABILITIES AND ANN_5

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Changes in Future Policy Benefit Reserves (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 31, 2022
Present value of expected future policy benefits
Future policy benefit reserves	$ 36,059		$ 37,689
Long-term care
Present value of expected net premiums
Balance, beginning of year	4,063	$ 4,059
Beginning balance at locked-in discount rate	3,745	3,958
Effect of changes in cash flow assumptions			17	$ 0
Effect of actual variances from expected experience			6	29
Adjusted beginning of year balance			3,769	3,987
Interest accrual	51	53
Net premiums collected	(98)	(103)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	3,721	3,936
Effect of changes in discount rate assumptions	211	281
Balance, end of period	3,932	4,217
Present value of expected future policy benefits
Balance, beginning of year	30,895	28,316
Beginning balance at locked-in discount rate	27,190	27,100	27,144	27,026
Effect of changes in cash flow assumptions			(7)	(11)
Effect of actual variances from expected experience			43	30
Adjusted beginning of year balance			27,180	27,046
Interest accrual	368	363
Benefit payments	(359)	(309)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	27,190	27,100
Effect of changes in discount rate assumptions	2,465	3,171
Balance, end of period	29,654	30,271
Future policy benefit reserves	25,722	26,054	26,832
Less: Reinsurance recoverables, net of allowance for credit losses	(165)	(204)
Net future policy benefit reserves, after reinsurance recoverables	25,557	25,850
Structured settlement annuities
Present value of expected net premiums
Balance, beginning of year	0	0
Beginning balance at locked-in discount rate	0	0
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			0	0
Adjusted beginning of year balance			0	0
Interest accrual	0	0
Net premiums collected	0	0
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	0	0
Effect of changes in discount rate assumptions	0	0
Balance, end of period	0	0
Present value of expected future policy benefits
Balance, beginning of year	9,357	8,860
Beginning balance at locked-in discount rate	8,484	8,730	8,561	8,790
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(29)	(1)
Adjusted beginning of year balance			8,532	8,789
Interest accrual	111	115
Benefit payments	(159)	(174)
Effect of foreign currency	0	0
Ending balance at locked-in discount rate	8,484	8,730
Effect of changes in discount rate assumptions	425	619
Balance, end of period	8,909	9,349
Future policy benefit reserves	8,909	9,349	9,357
Less: Reinsurance recoverables, net of allowance for credit losses	0	0
Net future policy benefit reserves, after reinsurance recoverables	8,909	9,349
Life
Present value of expected net premiums
Balance, beginning of year	4,803	4,828
Beginning balance at locked-in discount rate	4,773	5,210
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(2)	(35)
Adjusted beginning of year balance			4,771	5,175
Interest accrual	45	50
Net premiums collected	(70)	(73)
Effect of foreign currency	(69)	(23)
Ending balance at locked-in discount rate	4,678	5,129
Effect of changes in discount rate assumptions	(151)	(149)
Balance, end of period	4,527	4,979
Present value of expected future policy benefits
Balance, beginning of year	5,921	5,868
Beginning balance at locked-in discount rate	5,707	6,148	5,847	6,247
Effect of changes in cash flow assumptions			0	0
Effect of actual variances from expected experience			(13)	2
Adjusted beginning of year balance			5,833	$ 6,250
Interest accrual	55	60
Benefit payments	(109)	(138)
Effect of foreign currency	(73)	(24)
Ending balance at locked-in discount rate	5,707	6,148
Effect of changes in discount rate assumptions	(126)	(123)
Balance, end of period	5,581	6,025
Future policy benefit reserves	1,054	1,045	$ 1,117
Less: Reinsurance recoverables, net of allowance for credit losses	(29)	(57)
Net future policy benefit reserves, after reinsurance recoverables	$ 1,025	$ 988

INSURANCE LIABILITIES AND ANN_6

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Undiscounted and Discounted Expected Gross Premiums and Benefit Payments (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Long-term care
Liability for Future Policy Benefit, by Product Segment [Line Items]
Undiscounted, Gross premiums	$ 7,376	$ 7,924
Undiscounted, Benefit payments	62,774	64,944
Discounted, Gross premiums	4,794	5,105
Discounted, Benefit payments	29,654	30,271
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Undiscounted, Benefit payments	19,092	19,745
Discounted, Benefit payments	8,909	9,349
Life
Liability for Future Policy Benefit, by Product Segment [Line Items]
Undiscounted, Gross premiums	12,082	13,537
Undiscounted, Benefit payments	10,935	11,800
Discounted, Gross premiums	5,446	6,104
Discounted, Benefit payments	$ 5,581	$ 6,025

INSURANCE LIABILITIES AND ANN_7

INSURANCE LIABILITIES AND ANNUITY BENEFITS - Weighted-Average Durations and Interest Rates (Details)	Mar. 31, 2024	Mar. 31, 2023
Long-term care
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	12 years 4 months 24 days	13 years 2 months 12 days
Interest accretion rate	5.60%	5.50%
Current discount rate	5.20%	5%
Structured settlement annuities
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	10 years 9 months 18 days	11 years 2 months 12 days
Interest accretion rate	5.40%	5.40%
Current discount rate	5.20%	5%
Life
Liability for Future Policy Benefit, by Product Segment [Line Items]
Duration (years)	5 years 3 months 18 days	5 years 3 months 18 days
Interest accretion rate	5.20%	5.10%
Current discount rate	5%	4.80%

POSTRETIREMENT BENEFIT PLANS -

POSTRETIREMENT BENEFIT PLANS - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($) category	Mar. 31, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Number of categories \| category	3
Defined contribution plan costs	$ 89	$ 77
Deferred compensation expense	9	20
Principal retiree benefit
Defined Benefit Plan Disclosure [Line Items]
Plans income	36	36
Other pension
Defined Benefit Plan Disclosure [Line Items]
Plans income	$ 13	$ 29

POSTRETIREMENT BENEFIT PLANS _2

POSTRETIREMENT BENEFIT PLANS - Effect on Operations of Pension Plans (Details) - Principal pension - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Defined Benefit Plan Disclosure [Line Items]
Service cost for benefits earned	$ 21	$ 21
Expected return on plan assets	(578)	(594)
Interest cost on benefit obligations	453	474
Net actuarial loss amortization and other	(152)	(172)
Benefit plans expense (income)	$ (256)	$ (271)

CURRENT AND ALL OTHER LIABILI_2

CURRENT AND ALL OTHER LIABILITIES (Details) $ in Millions	3 Months Ended
CURRENT AND ALL OTHER LIABILITIES (Details) $ in Millions	Mar. 31, 2024 USD ($)
Other Liabilities Disclosure [Abstract]
Increase (decrease) in other current liabilities	$ (370)
Increase (decrease) in sales discounts and allowances	(107)
Increase (decrease) in interest payable	(65)
Increase (decrease) in taxes payable	(51)
Increase (decrease) in other noncurrent liabilities	347
Increase (decrease) in uncertain and other income taxes and related liabilities	295
Increase (decrease) in environmental, health and safety liabilities, noncurrent	$ 100

INCOME TAXES (Details)

INCOME TAXES (Details)	3 Months Ended
INCOME TAXES (Details)	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Effective income tax rate	17%	4.20%

SHAREHOLDERS' EQUITY - Schedule

SHAREHOLDERS' EQUITY - Schedule of Shareholders' Equity (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	$ 28,579
Ending balance	$ 31,104	$ 32,823
Dividends declared per common share (in dollars per share)	$ 0	$ 0.08
GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes	$ 195
Accumulated other comprehensive income (loss)
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(6,150)	$ (2,272)
Ending balance	(5,603)	(3,289)
Currency translation adjustments including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(3,623)	(5,893)
AOCI before reclass, net of taxes	(35)	152
Reclass from AOCI, net of taxes	0	2,234
Other comprehensive income (loss)	(35)	2,387
AOCI before reclasses, taxes	26	(5)
Reclass from AOCI, taxes	0	(626)
Currency translation adjustments including noncontrolling interests \| GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes	2,234
Currency translation adjustments attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	0	(1)
Currency translation adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	(35)	2,388
Ending balance	(3,658)	(3,505)
Benefit plans including noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	1,786	6,531
AOCI before reclass, net of taxes	(29)	(84)
Reclass from AOCI, net of taxes	(168)	(2,235)
Other comprehensive income (loss)	(197)	(2,319)
AOCI before reclasses, taxes	8	(13)
Reclass from AOCI, taxes	(52)	(594)
Benefit plans including noncontrolling interests \| GE HealthCare
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Reclass from AOCI, net of taxes	(2,030)
Benefit plans attributable to noncontrolling interests
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	2	(2)
Benefit plans
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Other comprehensive income (loss)	(200)	(2,317)
Ending balance	1,586	4,214
Investment securities and cash flow hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(959)	(1,927)
AOCI before reclass, net of taxes	(465)	718
Reclass from AOCI, net of taxes	11	(12)
Other comprehensive income (loss)	(453)	706
Ending balance	(1,412)	(1,222)
AOCI before reclasses, taxes	(116)	188
Reclass from AOCI, taxes	0	0
Long-duration insurance contracts
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax
Beginning balance	(3,354)	(983)
AOCI before reclass, net of taxes	1,236	(1,793)
Other comprehensive income (loss)	1,236	(1,793)
Ending balance	(2,119)	(2,776)
AOCI before reclasses, taxes	$ 328	$ (477)

SHAREHOLDERS' EQUITY - Narrativ

SHAREHOLDERS' EQUITY - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2024	Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]
Preferred stock, shares outstanding	2,795,444
Common stock, shares outstanding		1,094,606,676	1,088,415,995
Preferred stock
Accumulated Other Comprehensive Income (Loss) [Line Items]
Stock repurchased	$ 3,000

EARNINGS PER SHARE INFORMATIO_2

EARNINGS PER SHARE INFORMATION (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Diluted
Earnings (loss) from continuing operations	$ 1,522	$ 6,242
Preferred stock dividends and other and accretion of preferred share repurchase	0	(145)
Earnings (loss) from continuing operations attributable to common shareholders	1,522	6,097
Earnings (loss) from discontinued operations	14	1,257
Net earnings (loss) attributable to GE common shareholders	$ 1,537	$ 7,354
Total average equivalent shares (in shares)	1,091	1,089
Employee compensation-related shares (including stock options) (in shares)	11	8
Total average equivalent shares (in shares)	1,103	1,097
Earnings (loss) per share from continuing operations (in dollars per share)	$ 1.38	$ 5.56
Earnings (loss) per share from discontinued operations (in dollars per share)	0.01	1.15
Net earnings (loss) per share (in dollars per share)	$ 1.39	$ 6.71
Potentially dilutive securities (in shares)	12	38
Basic
Earnings (loss) from continuing operations	$ 1,522	$ 6,248
Preferred stock dividends and other and accretion of preferred share repurchase	0	(145)
Earnings (loss) from continuing operations attributable to common shareholders	1,522	6,103
Earnings (loss) from discontinued operations	14	1,257
Net earnings (loss) attributable to GE common shareholders	$ 1,537	$ 7,360
Total average equivalent shares (in shares)	1,091	1,089
Earnings (loss) per share from continuing operations (in dollars per share)	$ 1.39	$ 5.60
Earnings (loss) per share from discontinued operations (in dollars per share)	0.01	1.15
Net earnings (loss) per share (in dollars per share)	$ 1.41	$ 6.76
Preferred share redemption, excise tax		$ (30)

OTHER INCOME (LOSS) - Schedule

OTHER INCOME (LOSS) - Schedule of Other Income (Loss) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	$ 665	$ 5,906
Other net interest and investment income (loss)	252	186
Licensing and royalty income	67	34
Purchases and sales of business interests	9	(52)
Other items	25	4
Total other income (loss)	$ 1,109	$ 6,081
Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal, Statement of Income or Comprehensive Income [Extensible Enumeration]	Total other income (loss)	Total other income (loss)
Other (income) loss
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity method income	$ 128	$ 0
Retained and sold ownership interests
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	628	5,908
GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	616	6,093
AerCap
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	12	(195)
Baker Hughes
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Realized and unrealized gain (loss)	$ 0	$ 10

OTHER INCOME (LOSS) - Narrative

OTHER INCOME (LOSS) - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Dispositions of retained ownership interests, proceeds	$ 2,610	$ 2,025
GE HealthCare
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Equity securities, investment interest (in shares)	30.5
Equity securities, ownership percentage	6.70%
Dispositions of retained ownership interests, proceeds	$ 2,602
Dispositions of retained ownership interests, shares sold (in shares)	31.1

RESTRUCTURING CHARGES AND SEP_3

RESTRUCTURING CHARGES AND SEPARATION COSTS - Restructuring and Other Charges (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 233	$ 161
Restructuring and other charges cash expenditures	154	137
Cost of sales
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	105	36
Selling, general and administrative expenses
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	128	125
Operating segments \| Aerospace
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	10	4
Operating segments \| Renewable Energy
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	96	65
Operating segments \| Power
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	47	19
Corporate
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	80	72
Workforce reductions
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	141	66
Plant closures & associated costs and other asset write-downs
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	85	82
Acquisition/disposition net charges and other
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	7	12
Non-cash asset impairment, accelerated depreciation and other charges
Restructuring Cost and Reserve [Line Items]
Restructuring and other charges	$ 125	$ 75

RESTRUCTURING CHARGES AND SEP_4

RESTRUCTURING CHARGES AND SEPARATION COSTS - Changes in Restructuring Liability (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 918	$ 977
Additions	108	86
Payments	(137)	(87)
Effect of foreign currency and other	(4)	0
Ending balance	885	976
Restructuring reserve	885	976
Post-employment severance benefits
Restructuring Reserve [Roll Forward]
Ending balance	325	353
Restructuring reserve	$ 325	$ 353

RESTRUCTURING CHARGES AND SEP_5

RESTRUCTURING CHARGES AND SEPARATION COSTS - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restructuring Cost and Reserve [Line Items]
Separation costs	$ 355,000,000	$ 205,000,000
Payments for restructuring costs	137,000,000	87,000,000
Separation costs
Restructuring Cost and Reserve [Line Items]
Separation costs	355,000,000	205,000,000
Payments for restructuring costs	247,000,000	204,000,000
Restructuring, incurred net tax expense (benefit)	(54,000,000)	56,000,000
Separation costs \| Discontinued operations
Restructuring Cost and Reserve [Line Items]
Separation costs	0	20,000,000
Payments for restructuring costs	9,000,000	85,000,000
Restructuring, incurred net tax expense (benefit)	$ 0	$ (4,000,000)

FINANCIAL INSTRUMENTS - Assets

FINANCIAL INSTRUMENTS - Assets and Liabilities Not Carried at Fair Value (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Liabilities
Investment contracts (Note 13)	$ 1,486	$ 1,535
Carrying amount (net)
Assets
Loans and other receivables	2,453	2,438
Liabilities
Borrowings (Note 11)	20,525	20,965
Investment contracts (Note 13)	1,486	1,535
Estimated fair value
Assets
Loans and other receivables	2,333	2,379
Liabilities
Borrowings (Note 11)	20,037	20,689
Investment contracts (Note 13)	$ 1,547	$ 1,616

FINANCIAL INSTRUMENTS - Fair Va

FINANCIAL INSTRUMENTS - Fair Value of Derivatives (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Gross Notional	$ 55,045	$ 57,211
All other current assets
Derivative asset, statement of financial position	All other current assets (Note 10)	All other current assets (Note 10)
Gross derivatives	$ 878	$ 950
Netting and credit adjustments	(434)	(512)
Net derivatives in statement of financial position	$ 445	$ 437
All other current liabilities
Derivative liability, statement of financial position	All other current liabilities (Note 15)	All other current liabilities (Note 15)
Gross derivatives	$ 558	$ 671
Netting and credit adjustments	(432)	(510)
Net derivatives in statement of financial position	126	161
Qualifying currency exchange contracts
Derivative [Line Items]
Gross Notional	6,064	6,648
All other current assets
Gross derivatives	161	156
All other current liabilities
Gross derivatives	81	91
Non-qualifying currency exchange contracts and other
Derivative [Line Items]
Gross Notional	48,981	50,563
All other current assets
Gross derivatives	717	794
All other current liabilities
Gross derivatives	$ 477	$ 580

FINANCIAL INSTRUMENTS - Fair _2

FINANCIAL INSTRUMENTS - Fair Value Hedges, Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Cumulative amount of fair value hedging adjustments	$ 1,130		$ 1,226
Cumulative amount of fair value hedging on discontinued hedging relationships	1,130		1,226
Hedged liability	$ 8,803		$ 8,817
Hedged Liability, Statement of Financial Position [Extensible Enumeration]	Long-term borrowings (Note 11)	Long-term borrowings (Note 11)

FINANCIAL INSTRUMENTS - Effects

FINANCIAL INSTRUMENTS - Effects of Derivatives on AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative [Line Items]
Gain (loss) recognized in AOCI, cash flow hedges	$ 6	$ 28
Gain (loss) recognized in AOCI, net investment hedges	84	(62)
Reclassified from AOCI into earnings, investment hedges	0	0
Foreign currency debt
Derivative [Line Items]
Carrying value designated as net investment hedges	$ 4,655	$ 3,398

FINANCIAL INSTRUMENTS - Cash Fl

FINANCIAL INSTRUMENTS - Cash Flow and Net Investment Hedges, Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Pre-tax gain (loss) included in AOCI related to cash flow hedges of forecasted transactions	$ (25)
Loss expected to be transferred to earnings as an expense	$ 43
Maximum term of hedged forecasted transactions	12 years

FINANCIAL INSTRUMENTS - Effec_2

FINANCIAL INSTRUMENTS - Effects of Derivatives on Earnings (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Revenues	$ 16,053	$ 14,486
Interest Expense	278	269
SG&A	2,269	2,142
Other Income	12,729	16,810
Revenues
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash flow hedges	1	1
Non-hedging derivatives	0	2
Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash flow hedges	(2)	(2)
Non-hedging derivatives	0	0
SG&A
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash flow hedges	0	0
Non-hedging derivatives	43	115
Other Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Cash flow hedges	(4)	(2)
Non-hedging derivatives	$ (38)	$ (58)

FINANCIAL INSTRUMENTS - Counter

FINANCIAL INSTRUMENTS - Counterparty Credit Risk, Narrative (Details) - Counterparty credit risk - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Derivative [Line Items]
Exposure to counterparties including interest net collateral, excluding embedded derivatives	$ 381	$ 374
Net amount	$ 80	$ 120

VARIABLE INTEREST ENTITIES (Det

VARIABLE INTEREST ENTITIES (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Variable Interest Entity [Line Items]
Assets	$ 163,942	$ 163,045
Liabilities	132,838	134,466
Consolidated VIE
Variable Interest Entity [Line Items]
Assets	240	117
Liabilities	262	203
Unconsolidated VIEs
Variable Interest Entity [Line Items]
Assets	6,977	6,657
Unconsolidated VIEs \| Energy Financial Services
Variable Interest Entity [Line Items]
Assets	1,293	1,272
Unconsolidated VIEs \| Insurance
Variable Interest Entity [Line Items]
Assets	$ 5,447	$ 5,151

COMMITMENTS, GUARANTEES, PROD_2

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Commitments (Details) $ in Millions	Mar. 31, 2024 USD ($)
Investment commitments
Long-term Purchase Commitment [Line Items]
Commitments	$ 3,648
Run-off insurance operations
Long-term Purchase Commitment [Line Items]
Commitments	3,570
Run-off insurance operations, unconsolidated VIE investment commitment
Long-term Purchase Commitment [Line Items]
Commitments	3,515
Unfunded lending commitments
Long-term Purchase Commitment [Line Items]
Commitments	582
Aerospace \| Financial assistance
Long-term Purchase Commitment [Line Items]
Commitments	$ 2,676

COMMITMENTS, GUARANTEES, PROD_3

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Guarantees (Details) $ in Millions	Mar. 31, 2024 USD ($)
Credit support agreement
Guarantor Obligations [Line Items]
Maximum exposure	$ 909
Guarantee obligations, liability	17
Indemnification agreement, TMA \| GE HealthCare \| Continuing operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	35
Other indemnification agreements \| Continuing operations
Guarantor Obligations [Line Items]
Maximum exposure	285
Other indemnification agreements \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	710
Related reserves	69
Other indemnification agreements \| GE HealthCare \| Continuing operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	71
Guarantee of indebtedness of others \| Discontinued operations
Guarantor Obligations [Line Items]
Maximum exposure	25
Transition Services Agreement and Tax Matters Agreement \| GE HealthCare \| Discontinued operations
Guarantor Obligations [Line Items]
Guarantee obligations, liability	$ 77

COMMITMENTS, GUARANTEES, PROD_4

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Product Warranties (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Liability for product warranties	$ 1,999	$ 2,053

COMMITMENTS, GUARANTEES, PROD_5

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Alstom Legacy Matters (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Alstom Legacy Matters
Loss Contingencies [Line Items]
Loss contingency accrual	$ 391	$ 393

COMMITMENTS, GUARANTEES, PROD_6

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Shareholder and Related Lawsuits and GE Retirement Savings Plan Class Actions (Details) - GE retirement savings plan class actions	Mar. 31, 2024 proprietary_fund	Dec. 31, 2017 lawsuit
Loss Contingencies [Line Items]
Number of putative class actions \| lawsuit		4
Number of propriety funds, allegedly underperforming \| proprietary_fund	5

COMMITMENTS, GUARANTEES, PROD_7

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Bank BPH (Details) - Bank BPH litigation - Bank BPH - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2023	Mar. 31, 2024	Dec. 31, 2023
Related Party Transaction [Line Items]
Litigation settlement expense	$ 1,014
Estimate loss		$ 2,517	$ 2,669

COMMITMENTS, GUARANTEES, PROD_8

COMMITMENTS, GUARANTEES, PRODUCT WARRANTIES AND OTHER LOSS CONTINGENCIES - Environmental, Health and Safety Matters (Details) - USD ($) $ in Millions	Mar. 31, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Total reserves related to environmental remediation, nuclear decommissioning and worker exposure claims	$ 2,537	$ 2,465

SUBSEQUENT EVENT (Details)

SUBSEQUENT EVENT (Details) - Subsequent event $ in Billions	Apr. 02, 2024 USD ($)
GE Vernova \| Financial guarantees and trade finance instruments
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Maximum exposure	$ 1.5
GE Vernova \| Supply chain finance program and environmental matter
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Maximum exposure	2.3
Maximum exposure, not expected to exceed beyond one year	1.6
GE Vernova \| Indemnification agreement, technology costs, separation costs, severance costs, environmental matters and tax matters
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Guarantee obligations, liability	0.6
GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash balance	4.2
Cash and cash equivalents, held for sale	$ 0.1
Spinoff
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Stock conversion ratio	0.25
Spinoff \| GE Vernova
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Postretirement and pension plan benefit obligation	$ 1.7
Deferred compensation and benefit obligations	0.2
Cash contribution from GE	$ 0.5

SEGMENT OPERATIONS (Details)

SEGMENT OPERATIONS (Details) - USD ($) $ in Millions	3 Months Ended
SEGMENT OPERATIONS (Details) - USD ($) $ in Millions	Mar. 31, 2024	Mar. 31, 2023
Segment Reporting Information [Line Items]
Revenues	$ 16,053	$ 14,486
Revenues, V%	11%
Interest and other financial charges	$ (278)	(269)
Non-operating benefit income (cost)	362	385
Benefit (provision) for income taxes	(318)	(271)
Preferred stock dividends and other	0	(145)
Earnings (loss) from continuing operations attributable to GE common shareholders	$ 1,522	6,103
Earnings (loss) from continuing operations attributable to GE common shareholders, V%	(75.00%)
Earnings (loss) from discontinued operations attributable to GE common shareholders	$ 14	1,257
Earnings (loss) from discontinued operations attributable to GE common shareholders, V%	(99.00%)
Net earnings (loss) attributable to GE common shareholders	$ 1,537	7,360
Net earnings (loss) attributable to GE common shareholders, V%	(79.00%)
Operating segments
Segment Reporting Information [Line Items]
Revenues	$ 15,203	13,638
Revenues, V%	11%
Gross profit (loss)	$ 1,532	987
Gross profit (loss), V%	55%
Operating segments \| Aerospace
Segment Reporting Information [Line Items]
Revenues	$ 8,064	6,981
Revenues, V%	16%
Gross profit (loss)	$ 1,529	1,326
Gross profit (loss), V%	15%
Operating segments \| Renewable Energy
Segment Reporting Information [Line Items]
Revenues	$ 3,005	2,837
Revenues, V%	6%
Gross profit (loss)	$ (226)	(414)
Gross profit (loss), V%	45%
Operating segments \| Power
Segment Reporting Information [Line Items]
Revenues	$ 4,134	3,820
Revenues, V%	8%
Gross profit (loss)	$ 229	75
Corporate
Segment Reporting Information [Line Items]
Revenues	$ 850	848
Revenues, V%	0%
Gross profit (loss)	$ 276	5,456
Gross profit (loss), V%	(95.00%)
Corporate \| Energy Financial Services
Segment Reporting Information [Line Items]
Interest and other financial charges	$ (10)	(12)
Benefit (provision) for income taxes	62	51
Segment reconciling items
Segment Reporting Information [Line Items]
Interest and other financial charges	$ (267)	(257)
Interest and other financial charges, V%	(4.00%)
Non-operating benefit income (cost)	$ 362	385
Non-operating benefit cost (income), V%	(6.00%)
Benefit (provision) for income taxes	$ (380)	(322)
Benefit (provision) for income taxes, V%	(18.00%)
Preferred stock dividends and other	$ 0	$ (145)